A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Reference |
|---|
| "Atherosclerosis is the most important cause of coronary artery disease (CAD)." | ( Balcerzyk, A; Ciemniewski, Z; Dylag, S; Niemiec, P; Sarecka, B; Zak, I, 2005) |
| "Because atherosclerosis is a chronic inflammatory disease, we investigated whether the antiatherogenic effects of phytosterols are associated with reductions in proinflammatory cytokine production as well as the effect of this diet on global immunocompetence." | ( HayGlass, KT; Moghadasian, MH; Nashed, B; Yeganeh, B, 2005) |
| "Atherosclerosis is a dynamic multifaceted disease which affects the aorta and its major branches, characterized by the presence of lesions called atheromatous plaques." | ( Gamble, W, 2006) |
| "Atherosclerosis is the most important single factor contributing to this disease burden." | ( Henderson, KK; Laughlin, MH; Turk, JR; Vanvickle, GD; Watkins, J, 2005) |
| "Accelerated atherosclerosis is one of the major vascular complications of diabetes." | ( Duan, W; Paka, L; Pillarisetti, S, 2005) |
| "Atherosclerosis is a chronic disease of the vasculature that is influenced by multiple factors that involve a complex interplay between some components of the blood and the arterial wall." | ( Dogné, JM; Hanson, J; Pratico, D, 2005) |
| "Atherosclerosis is accelerated by diabetes and is associated with increased TXA(2) and other eicosanoids that stimulate TP." | ( Cayatte, AJ; Cohen, RA; Corda, S; Jiang, B; Lavielle, G; Maitland-Toolan, KA; Mastroianni, R; Oliver-Krasinski, JM; Shi, C; Verbeuren, TJ; Weisbrod, RM; Xu, S; Zang, M; Zuccollo, A, 2005) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall, where it associates with oxidative stress and formation of oxidized lipids." | ( Cyrus, T; Praticò, D; Tang, M; Vocun, L; Yao, Y, 2005) |
| "The etiology of atherosclerosis is complex and multifactorial but there is extensive evidence indicating that oxidized lipoproteins may play a key role." | ( Feingold, KR; Pan, XM; Rapp, JH; Staprans, I, 2005) |
| "Atherosclerosis is a multi-factorial condition involving dyslipidemia that can result in cardiovascular disease." | ( Liao, JK, 2005) |
| "Atherosclerosis is characterized by a persistent, low-grade inflammatory state in which immune cell activation is inseparably linked to plaque formation and destabilization." | ( Allison, AC; Hayden, MR; Kastelein, JJ; Stroes, ES; van Leuven, SI, 2006) |
| "Since atherosclerosis is now regarded as an inflammatory disease and those inflammatory cells play critical important roles in the initiation and development of atherosclerosis, we hypothesize that anti-atherogenic properties of fibrates may be largely due to their anti-inflammatory effects." | ( Ye, HJ; Zhao, SP, 2006) |
| "Atherosclerosis is a long-term chronic inflammatory disease associated with increased concentrations of inflammatory hepatic markers, such as CRP and fibrinogen, and of peripheral origin, such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-6." | ( Fruchart, JC; Gervois, P; Pauletto, P; Staels, B; Zambon, A, 2006) |
| "Atherosclerosis is associated with activation of innate immunity." | ( Godfraind, T, 2006) |
| "Atherosclerosis is a disease characterized by accumulation of lipids and fibrous elements in the innermost layer of the arterial wall." | ( Ishisaki, A; Matsuno, H, 2006) |
| "Atherosclerosis is pathogenically similar to a chronic inflammatory response." | ( Alberto Guzmán, L; Carolina Entrocassi, A; Cuffini, C; Eduardo Alonso, C; Martínez-Riera, L; Pedranti, M; Pilar Adamo, M; Rodríguez-Fermepín, M; Villegas, N; Zapata, M, 2006) |
| "Atherosclerosis is a disease characterized by lipid accumulation in the vascular wall leading to myocardial infarction or stroke." | ( Auwerx, J; Morozova, S; Suc-Royer, I, 2005) |
| "Atherosclerosis is considered a to be multifactorial disease driven by inflammatory reactions." | ( DeMaat, MP; Paffen, E, 2006) |
| "Atherosclerosis is an inflammatory disease, but the response of the endogenous anti-inflammatory system during this process has not been evaluated previously." | ( Boscá, L; Coronado, MT; de Prada, TP; Fantidis, P; Gonzalez, P; Pounchard, MA; Pozzi, AO, 2007) |
| "Atherosclerosis is a systemic diffuse disease that may manifest as an anglographically localized coronary, cerebral, mesenteric, renal, and/or peripheral arterial stenosis or as diffuse atherosclerosis." | ( Gau, GT; Wright, RS, 2006) |
| "Atherosclerosis is a long-term, chronic inflammatory disease that is exacerbated in patients with diabetes." | ( Anderson, JL; Horne, BD; Jensen, JR; Lanman, RB; Lavasani, F; May, HT; Muhlestein, JB; Pearson, RR; Wolfert, RL; Yannicelli, HD, 2006) |
| "Atherosclerosis is one of the major causes of morbidity and mortality in the western world." | ( Ameis, D; Illies, T; Zschenker, O, 2006) |
| "Atherosclerosis is a progressive process that initially involves endothelial dysfunction." | ( Jamborova, G; Nachtigal, P; Pospechova, K; Pospisilova, N; Semecky, V; Solichova, D; Zdansky, P, 2006) |
| "Atherosclerosis is a multifactorial inflammatory disease of blood vessels which decimates one in every three people in industrialized world." | ( Abdalla, DS; Baldissera, LP; Bock, PM; Cruz, LA; Curi, R; Gutierrez, LL; Heck, TG; Homem de Bittencourt, PI; Janner, DR; Krause, MS; Lagranha, CJ; Lagranha, DJ; Lima, T; Maslinkiewicz, A; Peralta, JS; Scola, G; Senna, SM; Tavares, AM, 2007) |
| "Atherosclerosis is enhanced in arterial segments exposed to disturbed flow." | ( Byrns, RE; Carpentiero, D; Casamassimi, A; D'Armiento, FP; de Nigris, F; Fiorito, C; Ignarro, LJ; Lerman, LO; Napoli, C; Schiano, C; Sica, V; Sumi, D; Williams-Ignarro, S, 2007) |
| "Atherosclerosis is a chronic inflammatory disease of the large arteries that is the primary cause of heart disease and stroke." | ( Burger, F; Chatenoud, L; Dean, Y; Elson, G; Kosco-Vilbois, M; Mach, F; Pelli, G; Steffens, S, 2006) |
| "Early stages of atherosclerosis are commonly noted in youth." | ( Barnard, RJ; Chen, AK; Roberts, CK, 2007) |
| "Atherosclerosis is a complex vascular inflammatory disease." | ( Guo, Y; Jiang, X; Li, FM; Ma, KF; Tang, BS; Wang, L; Wang, QZ; Zuo, YF, 2006) |
| "Atherosclerosis is a multifactorial disorder." | ( Harada-Shiba, M; Hidaka, A; Ichi, I; Inoue, K; Kojo, S; Kutsukake, S; Maruyama, T; Miwa, Y; Miyashita, Y; Nakahara, K; Tsushima, M, 2006) |
| "Atherosclerosis is an inflammatory response of the arterial wall to 'injury', which is prominently driven by inflammatory factors." | ( Li, M; Ren, H; Zhang, Y; Zhu, X, 2007) |
| "Atherosclerosis is a chronic inflammatory process, and anti-inflammatory agents potentially inhibit the development of atherosclerosis." | ( Chiba, T; Ishigami, A; Kaneko, E; Kondo, Y; Maruyama, N; Shimokado, K; Shinozaki, S; Umezawa, K, 2006) |
| "Because atherosclerosis is among the age-associated changes that almost always escape the influence of natural selection in humans, it might be reasonable to regard atherosclerosis as a feature of aging." | ( Komuro, I; Minamino, T, 2007) |
| "Atherosclerosis is a chronic inflammatory disease of the vasculature influenced by a variety of mediators." | ( Cyrus, T; Ding, T; Dogné, JM; Praticò, D; Yao, Y, 2007) |
| "Since atherosclerosis is a slowly progressive process at a young age, effective preventive measures should be taken early in life to prevent future events associated with cardiovascular disease." | ( Abe, Y; Aoyagi, K; Kadota, K; Kusano, Y; Maeda, T; Morishita, Y; Nagazumi, T; Nakazato, M; Takamura, N; Yagura, C, 2007) |
| "Atherosclerosis is often advanced before symptoms appear and it is not clear whether treatment is beneficial in middle-aged individuals with a low Framingham risk score (FRS) and mild to moderate subclinical atherosclerosis." | ( Bots, ML; Crouse, JR; Evans, GW; Grobbee, DE; O'Leary, DH; Palmer, MK; Raichlen, JS; Riley, WA, 2007) |
| "Atherosclerosis is now well recognised as a chronic inflammatory process which may ultimately lead to myocardial infarction, stroke and peripheral vascular disease." | ( Preiss, DJ; Sattar, N, 2007) |
| "Atherosclerosis is currently viewed as an inflammatory disease in which the initiation and progression of the atherosclerotic plaque towards a rupture prone, unstable plaque is driven by leukocyte recruitment mediated by various inflammatory mediators." | ( Biessen, EA; de Jager, SC; Jukema, JW; Kraaijeveld, AO; van Berkel, TJ, 2007) |
| "Atherosclerosis is an inflammatory response to accumulation of cholesterol in the artery wall." | ( Johnston, TP; Zhou, X, 2007) |
| "Atherosclerosis is a dynamic process." | ( Das, UN, 2007) |
| "Atherosclerosis is widely considered to be a chronic inflammatory disease." | ( Chen, L; Ding, H; Gurley, EC; Hu, W; Hylemon, PB; Jarujaron, S; Pandak, WM; Studer, E; Wang, JY; Zhou, H; Zou, T, 2007) |
| "Atherosclerosis is a disease of adult patients, however, it begins in childhood and progresses from fatty streaks to raised lesions in arteries in adolescence and young adults." | ( Baj, Z; Kaczmarek, P; Pokoca, L; Sierakowska-Fijałek, A; Smorag, I; Wosik-Erenbek, M, 2007) |
| "Atherosclerosis is considered to be an inflammatory disease that also involves oxidative stress." | ( Folkmann, JK; Hansen, CS; Loft, S; Møller, P; Risom, L, 2007) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Espinosa, B; Fortoul, T; Guevara, J; Masso, F; Montaño, LF; Paez, A; Rendon, E; Rodriguez, E; Varela, E, 2008) |
| "Atherosclerosis is a chronic inflammatory multifactorial disease in which immune responses are key pathogenetic factors." | ( Buttari, B; Delunardo, F; Margutti, P; Minetti, M; Ortona, E; Petrone, L; Pietraforte, D; Profumo, E; Riganò, R; Salvati, B; Siracusano, A, 2007) |
| "Atherosclerosis is a chronic inflammatory condition initiated in the endothelium in response to injury and maintained through the interactions between modified lipoproteins, macrophages, and arterial wall constituents." | ( Boyle, PJ, 2007) |
| "Hypertension and atherosclerosis are both characterized by insulin resistance, and we suggest that this plays a major role in their etiology." | ( Gill, V; Singal, P; Vasdev, S, 2007) |
| "Atherosclerosis is considered a low-grade inflammatory disease." | ( Andrés-Lacueva, C; Antúnez, E; Estruch, R; Fernández-Solá, J; Lamuela-Raventós, RM; Monagas, M; Nicolás, JM; Sacanella, E; Tobias, E; Vázquez-Agell, M; Zamora-Ros, R, 2007) |
| "Atherosclerosis is a chronic disease triggered by lipid disturbances, endothelial injury and sustained by inflammation." | ( Jankl, S; Kofler, S; Nickel, T; Schlichting, C; Weis, M, 2008) |
| "Atherosclerosis is a possibility in PAPS patients in their fourth decade of life or older." | ( Alves, JD; Ames, PR; Batuca, J; Iannaccone, L; Lopez, L; Margarita, A; Matsuura, E; Scenna, G, 2007) |
| "Atherosclerosis is the main underlying pathology of cardiovascular disease." | ( Chan, KC; Lin, CS; Lin, MC; Ueng, KC, 2007) |
| "The progression of atherosclerosis is accelerated and angiogenesis is impaired in CRF." | ( Bozina, N; Kes, P; Malenica, B; Reiner, Z; Sertic, J; Slavicek, J, 2007) |
| "Atherosclerosis is a multiple factors disease, in which the main roles play oxidant stress, endothelium dysfunction and disorders ofhemostasis." | ( Broncel, M, 2007) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall." | ( Chen, ZT; Lian, TW; Tu, YC; Wu, MJ; Yen, JH, 2007) |
| "Atherosclerosis is a chronic inflammatory disease in which the immune system plays an important role." | ( de Winther, MP; Duijvestijn, A; Gijbels, MJ; Heeringa, P; Smook, M; Tervaert, JW; van de Gaar, MJ; van Leeuwen, M, 2008) |
| "Atherosclerosis is currently concerned as a chronic inflammatory process, which is response to an endothelial damage." | ( Broncel, M; Chojnowska-Jezierska, J; Koziróg-Kołacińska, M, 2007) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Assayag, EB; Berliner, S; Bornstein, NM; Bova, I; Kesler, A; Shapira, I, 2008) |
| "Atherosclerosis is the leading cause of death in Western societies and a chronic inflammatory disease." | ( Borén, J; Braunersreuther, V; Camici, GG; Gersbach, M; Hassa, PO; Hottiger, MO; Lohmann, C; Lüscher, TF; Mach, F; Matter, CM; Odermatt, B; Stähli, BE; Tanner, FC; von Lukowicz, T, 2008) |
| "Accelerated atherosclerosis is the major cause of mortality in patients on chronic haemodialysis (HD)." | ( Apaydin, A; Capraz, I; Dursun, B; Dursun, E; Ozben, B; Ozben, T; Suleymanlar, G, 2008) |
| "Atherosclerosis is responsible for the vast majority of cardiovascular events." | ( Hamada, T; Kosaka, H; Mizukami, K; Murata, T; Narita, K; Sudo, S; Wada, Y; Yoshida, H, 2008) |
| "Atherosclerosis is a major global cause of morbidity and mortality, and diabetes patients are at increased risk of coronary heart disease development." | ( Knight, SC; Price, CL, 2007) |
| "Atherosclerosis is the leading cause of death and disability in the developed world." | ( Dueñas-Laita, A; Pérez-Castrillon, JL, 2006) |
| "Atherosclerosis is the underlying pathological process of most cardiovascular disease." | ( Ballinger, ML; Dadlani, H; Getachew, R; Little, PJ; Osman, N, 2008) |
| "Atherosclerosis is characterized by extensive thickening of the arterial intima partially resulting from deposition of collagen by vascular smooth muscle cells (SMCs)." | ( Eder, K; Gahler, S; Ringseis, R, 2008) |
| "Atherosclerosis is characterized by the thickening of the arterial wall and is the primary cause of coronary artery disease and cerebrovascular disease, two of the most common causes of illness and death worldwide." | ( Daugherty, A; Rader, DJ, 2008) |
| "Atherosclerosis is an example of an inflammatory disorder." | ( Anantharamaiah, GM; Fogelman, AM; Navab, M, 2008) |
| "Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are likely to present gender-specific differences with respect to their development, course, symptom complexes and prognosis." | ( Balbarini, A; Brevetti, G; Bucur, R; Chiariello, M; Melillo, E; Muratori, I; Novo, S, 2008) |
| "The risk of atherosclerosis is inversely related to circulating levels of high density lipoprotein (HDL) cholesterol." | ( Feig, JE; Fisher, EA; Shamir, R, 2008) |
| "Atherosclerosis is accelerated in diabetic patients." | ( Fang, F; Hua, X; Huang, CJ; Jian, R; Su, BH; Zheng, HT; Zhou, LN, 2008) |
| "Atherosclerosis is enhanced in arterial segments exposed to disturbed flow." | ( Balestrieri, ML; Crimi, E; D'Armiento, FP; De Rosa, G; Lerman, LO; Napoli, C; Schiano, C; Servillo, L; Sica, V, 2008) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall where both innate and adaptive immune responses contribute to disease initiation and progression." | ( Mallat, Z; Taleb, S; Tedgui, A, 2008) |
| "Atherosclerosis is a widespread disease caused by the deposition of lipids on arterial walls." | ( Banaszak, LJ; Ranatunga, WK, 2008) |
| "Atherosclerosis is the primary ischaemic vascular condition underlying a majority of cardiovascular disease related deaths." | ( Ivey, ME; Little, PJ; Osman, N, 2008) |
| "Atherosclerosis is considered to be a combined disorder of lipid metabolism and chronic inflammation." | ( Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Patton, D; Sunagawa, K; Tian, Q; Yano, K, 2008) |
| "Atherosclerosis is a complex disease process in which genetic, lipid, cellular, and immunological factors combine to determine the location, severity, and timing of lesion development and clinical events." | ( Chen, Y; Nie, R; Wang, J; Zhou, S, 2008) |
| "Atherosclerosis is linked to a number of oxidative events ranging from low-density lipoprotein (LDL) oxidation to the increased production of intracellular reactive oxygen species (ROS)." | ( Castilho, RF; Delgado, R; Oliveira, HC; Paim, BA; Pardo-Andreu, GL; Velho, JA; Vercesi, AE, 2008) |
| "Because atherosclerosis is an inflammatory disorder of the arterial intima, pharmacologic approaches have recently been developed to stabilize vulnerable, rupture-prone lesions through selective induction of macrophage autophagic death." | ( De Meyer, GR; Martinet, W, 2008) |
| "Atherosclerosis is a chronic inflammatory disease of the vasculature that is influenced by multiple factors and involves a complex interplay between some components of the bloodstream and the arterial wall." | ( Praticò, D, 2008) |
| "Atherosclerosis is now recognized as an inflammatory disease involving the vascular wall." | ( Chan, L; Gotlinger, KH; Ko, K; Merched, AJ; Serhan, CN, 2008) |
| "Atherosclerosis is a chronic inflammatory disease of the arteries resulting from interactions between lipids, monocytes, and arterial wall cells." | ( Choi, MS; Do, GM; Ha, TY; Jeon, SM; Kim, HJ; Kwon, EY; Park, T, 2008) |
| "Atherosclerosis is one of the most common causes of mortality in developed countries." | ( Baj, Z; Błaszczyk, J; Fijałkowski, P; Rysz, J; Sierakowska-Fijałek, A; Stepień, M; Wosik-Erenbek, M, 2008) |
| "Atherosclerosis is a chronic inflammatory disease regulated by immune mechanisms." | ( Abu Nabah, YN; Andrés, V; Gómez, M; Lamana, A; Sánchez-Madrid, F; Sanz-González, SM, 2009) |
| "Accurate imaging of atherosclerosis is a growing necessity for timely treatment of the disease." | ( Ali, A; Brannon-Peppas, L; Chu, K; Doiron, AL, 2008) |
| "Atherosclerosis is a dynamic inflammatory disorder." | ( Alavi, A; Bural, GG; Chen, W; Rader, DJ; Torigian, DA, 2009) |
| "Atherosclerosis is a disease affecting arterial blood vessels due to the accumulation of macrophage white blood cells and low density lipoproteins." | ( Annapurna, A; Reddy, YN; Srinivas, M, 2008) |
| "Atherosclerosis is a chronic inflammatory disease in which the renin-angiotensin-aldosterone system plays an important role." | ( Chen, Y; Cheng, X; Ding, YJ; Liao, MY; Liao, YH; Tang, TT; Xie, JJ; Yao, R; Yu, X, 2010) |
| "Atherosclerosis is accelerated in both type 1 and type 2 diabetes." | ( Bornfeldt, KE; Chait, A, 2009) |
| "Atherosclerosis is increasingly recognized as a chronic inflammatory disease." | ( Jha, HC; Mittal, A; Prasad, J, 2008) |
| "Atherosclerosis is characterized by inflammatory responses of the arterial wall to "injury", which is prominently driven by inflammatory mediators." | ( Cheng, S; Ge, S; Liu, D; Liu, X; Xu, G; Xu, J; Zhou, G, 2009) |
| "Atherosclerosis is often related to vascular endothelial dysfunction." | ( Andersson, IJ; Davidge, ST; Jiang, YY, 2009) |
| "Atherosclerosis is a complex pathological condition caused by a number of mechanisms including the accelerated proliferation of vascular smooth muscle cells (VSMCs)." | ( Chen, X; Jiang, X; Krauss, S; Sun, G; Xiang, Y; Zhang, CY; Zhang, H; Zhang, J; Zhang, Y; Zhu, L, 2009) |
| "Atherosclerosis is considered as a chronic inflammatory response in arterial blood vessels." | ( Hao, H; Jiang, YJ; Wang, YY; Xue, S; Yin, BL, 2009) |
| "Although atherosclerosis is associated with the elderly, young adults with hypercholesterolemia and other cardiovascular risk factors may have subclinical atherosclerotic disease." | ( Nasir, K; Santos, RD, 2009) |
| "The atherosclerosis is associated with increased arterial stiffness, endothelial dysfunction and elevated oxidative stress and inflammation." | ( Coombes, JS; Driver, R; Fassett, RG; Geraghty, DP; Healy, H; Ranganathan, D; Ratanjee, S; Robertson, IK; Sharman, JE, 2009) |
| "Atherosclerosis is a chronic progressive disease that is a major contributor to cardiac death." | ( Anwar, F; Anwar, K; Chan, ES; Reiss, AB, 2009) |
| "Atherosclerosis is an inflammatory disease of the wall of large- and medium-sized arteries that is precipitated by elevated levels of low-density lipoprotein (LDL) cholesterol in the blood." | ( Galkina, E; Ley, K, 2009) |
| "Carotid atherosclerosis is associated with cognitive decline in elderly people." | ( Errea, JM; García-Gómara, MJ; Modrego, PJ; Pérez Trullen, JM; Rios, C, 2009) |
| "Atherosclerosis is a complex process in which the immune system and the endothelium appear to play a prominent role." | ( Afek, A; George, J; Keren, G; Kogan, E; Maysel-Auslender, S; Mor, A; Regev, E; Rubinstein, A, 2009) |
| "Atherosclerosis is the leading cause of death worldwide." | ( Feig, JE; Fisher, EA; Quick, JS, 2009) |
| "Atherosclerosis is a common disease of the arteries and it occurs in areas around the branching site of blood vessels where the cells are exposed to low fluid shear stress." | ( Kano, Y; Katoh, K; Ookawara, S, 2008) |
| "Atherosclerosis is a chronic inflammatory disease resulting from interactions between lipids, macrophages and arterial wall cells." | ( Aoyama, T; Cheng, XW; Kikuchi, R; Liao, JK; Murohara, T; Takeshita, K; Yamamoto, K, 2009) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of oxidized lipoproteins and apoptotic cells." | ( Bäckhed, F; Binder, CJ; Choi, J; Chou, MY; Corr, M; Fogelstrand, L; Hansen, LF; Hartvigsen, K; Hörkkö, S; Miller, YI; Perkmann, T; Shaw, PX; Witztum, JL; Woelkers, D, 2009) |
| "Atherosclerosis is thought to be associated with endoplasmic reticulum (ER) dysfunction and the accumulation of unfolded proteins." | ( Hideshima, M; Ishii, Y; Kurokawa, M; Kyuwa, S; Yoshikawa, Y, 2009) |
| "Atherosclerosis is promoted by a combination of hypercholesterolemia and vascular inflammation." | ( Abbas, A; Ahmad, S; Ahmed, A; Al-Ani, B; Bhandari, V; Chudasama, K; Cudmore, M; Findley, CM; Fujisawa, T; Hewett, PW; Huang, J; Kontos, CD; Lam, GK; Niu, XL; Potluri, R, 2009) |
| "The role of cAMP in atherosclerosis is not widely accepted and incompletely characterized." | ( Fantidis, P, 2010) |
| "Atherosclerosis is a chronic inflammatory condition of the vascular wall that may result in an acute clinical event by inducing plaque rupture/erosion leading to thrombosis." | ( Bechlioulis, A; Calis, KA; Kalantaridou, SN; Makrigiannakis, A; Michalis, L; Naka, KK, 2010) |
| "Atherosclerosis is a complex pathologic process in which chemokine-mediated leukocyte accumulation in arterial walls is thought to be an important mechanism of pathogenesis." | ( Barlic, J; Murphy, PM; Zhu, W, 2009) |
| "Atherosclerosis is an inflammatory disease with T cell-driven immunoinflammatory responses contributing to disease initiation and progression." | ( Feng, J; Kong, W; Liu, B; Wang, X; Xu, Q; Zhang, Z, 2009) |
| "Atherosclerosis is a complicated and multifactorial disease, induced not only by genotype, but also, even more importantly, by environmental factors." | ( A, J; Cao, B; Gu, S; Hao, H; Huang, Q; Ren, H; Sun, J; Wang, G; Yan, B; Zha, W; Zhang, Y; Zhu, X, 2009) |
| "Atherosclerosis is characterized by a complex immune response in the vessel wall, involving both inflammation and autoimmune processes." | ( Devergne, O; Heinz, P; Kempe, S; Kokai, E; Marx, N; Wirth, T, 2009) |
| "Suppression of atherosclerosis is associated with lowering of serum lipids and antioxidant activity." | ( Prasad, K, 2009) |
| "Premature atherosclerosis is a characteristic feature of systemic lupus erythematosus." | ( Reiss, AB, 2009) |
| "Atherosclerosis is main cause of arteriosclerosis." | ( Bae, K; Kang, KW; Kim, SK; Lee, MY; Oh, WK; Pokharel, YR; Su, ND; Thuong, PT, 2009) |
| "Atherosclerosis is a disease with three main components: increased blood lipoprotein/cholesterol and their deposition in the arterial wall, an important Th1-mediated proinflammatory reaction and thrombogenic status." | ( Alvarez-Leite, JI; Fernandes, LR; Portugal, LR, 2009) |
| "Atherosclerosis is an inflammatory condition characterised by an abundance of activated immunocompetent cells in plaques which cause cardiovascular disease (CVD) when they rupture." | ( Frostegård, J, 2010) |
| "Atherosclerosis is a cardiovascular disease; however, there is little information on signal transduction for vascular function in the early stage of atherosclerosis." | ( Fujimoto, S; Ito, J; Mori-Kawabe, M; Tada, T; Tsushima, H, 2009) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the presence of activated immune-competent cells in the lesions, producing mainly proinflammatory cytokines." | ( de Faire, U; Frostegård, J, 2009) |
| "Atherosclerosis is a chronic and progressive inflammatory vascular disease that is characterized by a complex interplay between some components of the bloodstream and the arterial wall." | ( Dogné, JM; Praticò, D, 2009) |
| "Atherosclerosis is one of the major complications of diabetes, which may result from insulin resistance via mitochondrial dysfunction." | ( Ahn, SY; Choi, YS; Jeong, JH; Kim, M; Koo, HJ; Pak, YK; Park, WH; Piao, Y, 2010) |
| "Atherosclerosis is the primary independent risk factor of cardiovascular disease, and Liver X Receptors (LXRalpha and LXRbeta) activation may play an anti-atherosclerosis effect." | ( Li, Y; Zhu, Y, 2009) |
| "Atherosclerosis is a chronic inflammatory disease, which selectively involves the arteries in the vascular system." | ( Kocaman, SA, 2009) |
| "Atherosclerosis is a chronic inflammatory disease in the vessel." | ( Guo, F; Liu, J; Liu, N; Lu, P; Wang, C, 2009) |
| "Early-stage atherosclerosis is present in newly diagnosed, untreated T2DM and IGT patients, and it may be that its early assessment, along with good control of hypertension and hyperglycaemia, will help to delay its progression." | ( Du, Y; Feng, X; Gong, W; Hu, R; Li, Q; Lu, B; Pan, Y; Wang, M; Yang, Y; Yang, Z; Ye, W; Zhang, W; Zhang, Y; Zhou, W; Zhu, X, 2009) |
| "Atherosclerosis is a chronic inflammatory disease associated with the accumulation of oxidized lipids in arterial lesions." | ( Brophy, L; Garelnabi, M; Litvinov, D; Parthasarathy, S; Selvarajan, K, 2010) |
| "Atherosclerosis is an inflammatory disease involving activation of adaptive and innate immune responses to modified lipoproteins." | ( Hansson, GK; Hermansson, A; Hjerpe, C; Johansson, D; Zhou, X, 2010) |
| "Atherosclerosis is associated with Alzheimer's disease (AD) in humans, but the nature of this link is still elusive." | ( Arnaboldi, L; Catapano, AL; Corsini, A; Ferrarese, C; Maggi, A; Meda, C; Norata, GD; Piazza, F; Tibolla, G; Uboldi, P; Vegeto, E, 2010) |
| "Atherosclerosis is an inflammatory-immune mediated disease process." | ( Bui, QT; Wilensky, RL, 2010) |
| "Atherosclerosis is the leading cause of illness and death." | ( Fiorucci, S; Mencarelli, A, 2010) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Peng, DQ; Wang, SH; Yuan, SG; Zhao, SP, 2010) |
| "Atherosclerosis is linked to inflammation." | ( Annema, W; Buijs, RV; de Boer, JF; Heeringa, P; Nijstad, N; Tietge, UJ; Tölle, M; van der Giet, M, 2010) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Dai, FM; Huang, YS; Lu, JM; Sun, L; Wang, LX; Wang, SR; Wu, Y; Xu, BS; Zhao, SC, 2009) |
| "Atherosclerosis is a disease process which develops at the arterial branches and curvatures of medium to large arteries." | ( Bishop, E; Cockcroft, NY; Cunningham, F; Fearon, IM; Gaça, MD; Oke, O; Zantl, R, 2009) |
| "Atherosclerosis is considered to be a chronic inflammatory disease." | ( Huang, B; Miao, J; Su, H; Su, L; Wang, L; Zhang, L; Zhang, S; Zhang, Y; Zhao, J, 2010) |
| "Atherosclerosis is an inflammatory disease." | ( Fredrikson, GN; Gerdes, N; Hansson, GK; Hermansson, A; Holmgren, J; Ketelhuth, DF; Klingenberg, R; Lebens, M; Nilsson, J; Rudling, M; Strodthoff, D, 2010) |
| "The burden of atherosclerosis is particularly high in western countries in terms of mortality and disability." | ( Di Legge, S; Rotondo, F; Sallustio, F; Stanzione, P, 2010) |
| "Atherosclerosis is the major cause of cardiovascular morbidity and mortality." | ( Schuchardt, M; Tölle, M; van der Giet, M, 2010) |
| "Atherosclerosis is a chronic inflammatory disease of middle sized and large vessels with sequelae comprising the most frequent causes of death in the Western world." | ( Bartenstein, P; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T, 2010) |
| "Atherosclerosis is increasingly recognised as an inflammatory disease." | ( Mackness, B; Mackness, M, 2010) |
| "While atherosclerosis is not yet clinically validated, Wyeth's LXRalpha/beta agonist LXR-623 indicated the key LXR target genes involved in RCT (ABCA1 and ABCG1) are upregulated in peripheral blood cells in a dose-dependent manner." | ( Li, X; Molteni, V; Yeh, V, 2010) |
| "Peripheral atherosclerosis is the leading cause of chronic lower limb ischemia (PAD)." | ( Adamiec, R; Sapian-Raczkowska, B; Zdrojowy, K, 2010) |
| "Atherosclerosis is a chronic inflammatory disease of the arteries that is characterised by the activation of endothelial cells, the recruitment of monocytes into the vessel wall and the differentiation of recruited macrophages into cholesterol-laden foam cells." | ( Erridge, C, 2009) |
| "Atherosclerosis is the most frequent cause of CV complications in patients with end-stage renal disease (ESRD)." | ( Alamdaran, SA; Eliasi, S; Moallem, SA; Mohammadpour, AH; Nazemian, F; Shamsara, J, 2011) |
| "Atherosclerosis is a chronic, complex, and progressive pathological process in large and medium sized arteries." | ( Chaoshu, T; Hongfang, J; Junbao, D; Qiao, W, 2010) |
| "Atherosclerosis is accelerated in people with systemic lupus erythematosus, and the presence of dysfunctional, pro-inflammatory high-density lipoproteins is a marker of increased risk." | ( Anderson, M; Hahn, BH; Iikuni, N; La Cava, A; Lai, CK; Le, E; Lourencço, EV; McMahon, M; Skaggs, B, 2010) |
| "Coronary atherosclerosis is a leading cause of death in the United States and worldwide, accounting for close to 1 million deaths annually in the United States alone." | ( Gill, EA, 2010) |
| "An early feature of atherosclerosis is vascular endothelial inflammatory change." | ( Hara, Y; Kamibayashi, M; Okada, M; Usui, T; Yamawaki, H, 2010) |
| "Atherosclerosis is a chronic inflammatory and autoimmune disease." | ( Dulin, E; García-Barreno, P; Guisasola, MC, 2010) |
| "Atherosclerosis is now recognized as a chronic inflammatory disease." | ( Fu, H; Guo, Y; Huang, H; Liu, X; Luo, F; Pan, P; Wu, W; Zhang, L, 2010) |
| "Atherosclerosis is an inflammatory disease in the vessel." | ( Han, C; Li, M; Liu, J; Liu, X, 2010) |
| "The ARMDS and atherosclerosis are distinct entities, but are often overlapped and confused with each other." | ( Sawabe, M, 2010) |
| "Atherosclerosis is a chronic inflammatory disease occurring within the artery wall and is an underlying cause of cardiovascular complications, including myocardial infarction, stroke and peripheral vascular disease." | ( Wilson, HM, 2010) |
| "Atherosclerosis is an inflammatory disease." | ( Arora, R; Racherla, S, 2012) |
| "Atherosclerosis is a chronic inflammatory disease of multiple etiologies." | ( Dhale, MA; Gaonkar, V; Keni, S; Puttananjaiah, MK, 2011) |
| "Atherosclerosis is influenced by the interaction of environmental and genetic susceptibility risk factors." | ( Acevedo, F; Hixson, JE; Mak, S; Shimmin, LC; Sun, H; Teng, BB; Zhao, L, 2010) |
| "Atherosclerosis is known to be an inflammatory disease and there is increasing evidence that chylomicron remnants (CMR), the lipoproteins which carry dietary fats in the blood, cause macrophage foam cell formation and inflammation." | ( Avella, M; Bejta, F; Bentley, C; Botham, KM; De Pascale, C; Hathaway, N; Lawson, C; Wheeler-Jones, CP; Widdows, J, 2011) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Guo, F; Ji, Y; Liu, J; Liu, N; Lu, P; Wang, C, 2011) |
| "Atherosclerosis is a chronic inflammatory disease of the vessel wall." | ( Conte, MS; Creager, MA; Ho, KJ; Kroemer, AH; Lancero, H; Owens, CD; Pande, R; Serhan, CN; Spite, M, 2010) |
| "Atherosclerosis is an inflammatory disorder of arteries." | ( Cao, M; Hermonat, PL; Kang, BY; Khan, JA; Liu, Y; Mehta, JL, 2010) |
| "Atherosclerosis is a common disease in pet birds, particularly in psittacines, and is frequently found when performing postmortem examinations on adult and old dogs, in which it is mainly associated with endocrine diseases, such as hypothyroidism and diabetes mellitus." | ( Bourgeois, A; Chai, N; Charpentier, M; Lemberger, K; Schilliger, L, 2010) |
| "Usually atherosclerosis is caused by the combined effects of multiple risk factors." | ( Cooney, HC; Cooney, MT; Dudina, A; Graham, IM, 2010) |
| "Atherosclerosis is suggested to have a detrimental effect on anastomotic healing." | ( Dijk, JW; Havenga, K; Hermans, J; Kleinrensink, GJ; Klitsie, P; Komen, N; Lange, JF; Oudkerk, M; Slieker, J; Weyler, J, 2011) |
| "Atherosclerosis is accelerated in the setting of diabetes, but the factors driving this phenomenon remain elusive." | ( Burch, ML; Evanko, S; Little, PJ; Osman, N; Tannock, LR; Yang, SN, 2010) |
| "Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive immuno-inflammatory mechanisms are involved." | ( Haron, MM; Houssen, ME; Ibrahim, TM; Metwally, SS, 2011) |
| "Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs)." | ( Borén, J; Handschin, C; Lohmann, C; Lüscher, TF; Matter, CM; Stein, S; Stenfeldt, E, 2010) |
| "Atherosclerosis is an inflammation-based complex vascular disorder which causes coronary artery disease, stroke and peripheral artery disease." | ( Ishibashi, T; Takeishi, Y, 2011) |
| "The risk for atherosclerosis is increased in postmenopausal women." | ( Hao, Q; Li, DJ; Wang, L; Wang, WJ; Wang, YD, 2011) |
| "Atherosclerosis is a leading cause of death worldwide." | ( Conolly, SM; Douglas, T; Kosuge, H; McConnell, MV; Terashima, M; Tsao, PS; Uchida, M; Young, MJ, 2011) |
| "Atherosclerosis is a lipid deposition and inflammatory disease that results in considerable morbidity and mortality worldwide." | ( Jaffer, FA, 2011) |
| "Atherosclerosis is an inflammatory disease of vascular wall initiated and amplified by oxidative stress." | ( Aoyama, T; Minatoguchi, S, 2011) |
| "Atherosclerosis is common in patients with chronic kidney disease (CKD), and cardiovascular disease (CVD) represents a major cause of death in these patients, especially, in patients with end-stage renal disease(ESRD)." | ( Koike, M; Nitta, K, 2011) |
| "Atherosclerosis is a progressive disease characterized by a series of inflammatory responses in the large and medium arteries." | ( Lee, J; Liu, X; Shang, F; Wang, H; Wang, Z; Zhang, Y; Zheng, Q, 2011) |
| "Atherosclerosis is the principal cause of mortality in industrialized countries." | ( Cherdon, C; de Leval, L; Defraigne, JO; Dogné, JM; Drion, P; Hanson, J; Masereel, B; Michiels, C; Ooms, A; Pirotte, B; Rolin, S; Sakalihassan, N, 2011) |
| "Atherosclerosis is an inflammatory disease that involves the arterial wall and is characterised by the progressive accumulation of lipids in the vessel wall." | ( Badimon, L; Storey, RF; Vilahur, G, 2011) |
| "Atherosclerosis is an inflammatory disease that causes most myocardial infarctions, strokes and acute coronary syndromes." | ( Bordes, S; Joshi, F; Rosenbaum, D; Rudd, JH, 2011) |
| "Atherosclerosis is thought to initiate at sites of endothelial cell injury." | ( Andrews, AM; Barbee, KA; Clyne, AM; Figueroa, DS; Kemeny, SF, 2011) |
| "Accelerated atherosclerosis is the leading cause of death in type 1 diabetes, but the mechanism of type 1 diabetes-accelerated atherosclerosis is not well understood, in part due to the lack of a good animal model for the long-term studies required." | ( Breslow, JL; King, N; Pridgen, B; Xu, J; Zhou, C, 2011) |
| "Atherosclerosis is an inflammatory and thrombotic disease." | ( Ersoy, M; Gerdes, N; Hansson, GK; Hermansson, A; Hjemdahl, P; Hu, H; Li, N; Zhu, L, 2011) |
| "Atherosclerosis is a multifactorial, long-lasting process in humans." | ( Imaizumi, K, 2011) |
| "Atherosclerosis is a multifactorial disease with several mechanisms participating in its manifestation." | ( Katselou, MG; Kourounakis, AP; Matralis, AN; Nikitakis, A, 2011) |
| "Atherosclerosis is a chronic inflammatory disease affecting medium and large arteries resulting from a complex interaction between genetic and environmental risk factors that include dyslipidemia, hypertension, diabetes mellitus, and smoking." | ( Chyu, KY; Peter, A; Shah, PK, 2011) |
| "Accelerated atherosclerosis is a major diabetic complication initiated by the enhanced recruitment of monocytes into the vasculature." | ( Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q, 2011) |
| "Atherosclerosis is a diffuse and highly variable disease of arteries that alters the mechanical properties of the vessel wall through highly variable changes in its cellular composition and histological structure." | ( Apostolakis, E; Dougenis, D; Karanikolas, M; Koletsis, E; Koniari, I; Mandellou, M; Mavrilas, D; Papadaki, H; Papalois, A, 2011) |
| "A common feature of atherosclerosis is vascular mineralization." | ( Bruedigam, C; Chiba, H; Eijken, M; Koedam, M; van Leeuwen, JP, 2011) |
| "Accelerated atherosclerosis is the major cause of mortality in patients on chronic haemodialysis (HD)." | ( Alp, H; Ari, E; Asicioglu, E; Bakan, E; Beytur, A; Cebi, A; Demir, H; Gecit, I; Kaya, Y; Soylemez, N, 2012) |
| "Atherosclerosis is an inflammatory immune disease associated with lipid accumulation in the intima layer of arteries." | ( Alvarez-Leite, JI; Fernandes, LR; Neto, NN; Rezende, AB; Ribeiro, AC; Teixeira, HC, 2011) |
| "Atherosclerosis is influenced by multiple environmental factors that involve a complex interaction between blood components and the arterial wall and is characterized by inflammatory reactions." | ( Kim, KH; Kim, KS; Kim, SJ; Lee, WR; Park, JH; Park, KK, 2011) |
| "Atherosclerosis is a major cause of cardiovascular disease caused by high cholesterol." | ( Choi, MS; Ha, TY; McGregor, RA; Shin, SK, 2011) |
| "Dyslipidemia and atherosclerosis are associated with reduced insulin sensitivity and diabetes, but the mechanism is unclear." | ( Accili, D; Gu, W; Kim-Muller, JY; Lin, HV; Qiang, L; Welch, CL, 2011) |
| "Atherosclerosis is the main cause of cardiovascular disease, but the extent of atherosclerosis in individual patients is difficult to estimate." | ( Bjerre, M; Flyvbjerg, A; Frystyk, J; Galatius, S; Iversen, AZ; Jensen, JS; Mogelvang, R; Pedersen, SH, 2012) |
| "Atherosclerosis is characterized by multiple key events including endothelial dysfunction, monocyte infiltration and their differentiation into macrophages, conversion of lesion-resident macrophages into foam cells, and smooth muscle cell proliferation." | ( Austin, RC; Lynn, EG, 2011) |
| "As atherosclerosis is a lifelong process, prevention of exposure to its risk factors should start at an early age." | ( Ala-Korpela, M; Jokinen, E; Jula, A; Lagström, H; Niinikoski, H; Pahkala, K; Raitakari, OT; Rönnemaa, T; Savolainen, MJ; Simell, O; Viikari, J, 2012) |
| "Atherosclerosis is an important cardiovascular disease, becoming a major and increasing health problem in developed countries." | ( Chen, ZF; DU, JB; Jin, HF; Li, W; Tang, CS; Tang, XY; Zhao, B; Zhu, LL, 2011) |
| "Atherosclerosis is a chronic inflammatory disease initiated by monocyte recruitment and retention in the vessel wall." | ( Berliner, JA; Ho, T; Lee, S; Lusis, AJ; Nguyen, P; Palvolgyi, R; Parks, BW; Romanoski, CE; Springstead, JR, 2012) |
| "Atherosclerosis is a chronic, inflammatory disorder characterized by the deposition of excess lipids in the arterial intima." | ( Li, P; Ye, J; Yuan, Y, 2012) |
| "Atherosclerosis is an important underlying pathology of cardiovascular diseases." | ( Liu, LL; Song, Z; Wu, YQ; Xing, SH; Zhou, CH, 2012) |
| "Functional atherosclerosis is present in inflammatory bowel disease before early structural changes occur in vasculature." | ( Akarsu, M; Akpinar, H; Cullu, N; Demir, S; Goktay, Y; Kayahan, H; Sari, I; Unsal, B; Yuksel, F, 2012) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipid-loaded macrophages in the arterial wall." | ( Aderem, A; Gold, ES; Moritz, RL; Podolsky, I; Ramsey, SA; Rodriguez, DJ; Sartain, MJ; Selinummi, J, 2012) |
| "Atherosclerosis is accelerated in rheumatoid arthritis (RA) and psoriatic arthritis (PsA)." | ( Buttari, B; Di Franco, M; Filesi, C; Masella, R; Profumo, E; Riganò, R; Saso, L; Scarno, A; Scrivo, R; Spadaro, A; Tosti, ME, 2012) |
| "Atherosclerosis is a chronic systemic inflammatory disease." | ( Acin, F; Bleda, S; De Haro, J; Esparza, L, 2012) |
| "Atherosclerosis is a chronic inflammatory disease characterized by increased expression of adhesion molecules, which contribute to monocytes adhesion to vascular endothelial cells (VECs)." | ( Dai, M; Wang, YQ; Yin, DK; Zhong, JC, 2012) |
| "Aging and atherosclerosis are well-recognized risk factors for cardiac and neurovascular diseases." | ( Badaut, J; Copin, JC; da Silva, RF; Fukuda, AM; Gasche, Y; Schaller, K, 2012) |
| "Atherosclerosis is a chronic inflammatory disease of multifactorial origin, which occurs in response to endothelial injury." | ( Brito, LF; Matta, SL; Peluzio, Mdo C; Queirós, LD; Queiroz, JH; Ribeiro, SM, 2012) |
| "The severity of atherosclerosis is primarily determined by overall lipid metabolism and the degree of inflammation present within the vessel wall." | ( Cao, F; Chen, J; Guo, W; Li, C; Li, W; Narsinh, K; Qi, S; Sun, D; Wei, G; Zhang, Z; Zhao, L, 2012) |
| "Because atherosclerosis is a chronic inflammatory disease that remains on the rise, understanding in more detail how apoE controls immune cell activation and function is of much interest." | ( Raffai, RL, 2012) |
| "Atherosclerosis is a chronic inflammatory condition that affects the arterial wall." | ( Eshraghian, MR; Keshavarz, SA; Mottaghi, A; Rejali, L; Rezaei, N; Saboor-Yaraghi, AA; Salehi, E; Sezavar, H, 2012) |
| "Atherosclerosis is a chronic and progressive inflammatory disease." | ( Chae, IG; Chun, KS; Im, NK; Jung, YT; Lee, IS; Lee, J; Yu, MH, 2012) |
| "Atherosclerosis is considered as a moderate systemic inflammation and we hypothesise that this chronic condition could have an impact on the outcome in sepsis." | ( Boettel, J; Breuel, H; Kabisch, B; Lösche, W; Otto, GP; Sossdorf, M; Winning, J, 2013) |
| "Atherosclerosis is widely regarded as a chronic inflammatory disease that develops as a consequence of entrapment of oxidized low-density lipoprotein (LDL) in the arterial intima and its interaction with components of both innate and adaptive immunity." | ( Bhakdi, S; Torzewski, M, 2013) |
| "Accelerated atherosclerosis is a hallmark of chronic kidney disease (CKD)." | ( Fliser, D; Friedrich, A; Geisel, J; Grün, OS; Heine, GH; Hummel, B; Rogacev, KS; Rotter, B; Winter, P; Zawada, AM, 2012) |
| "Atherosclerosis is a multifactorial and progressive disease in which the inflammatory reaction and inflammation-related factors play important roles at all stages." | ( An, HJ; Kim, KH; Kim, KS; Lee, CK; Lee, WR; Min, BK; Park, KK; Park, YY, 2013) |
| "Atherosclerosis is a major manifestation of the pathophysiology underlying cardiovascular disease." | ( Deng, Q; Huang, F; Huang, Q; Xu, J; Yang, J; Yang, W, 2012) |
| "Atherosclerosis is characterized as a chronic inflammatory condition that involves cholesterol deposition in arteries." | ( Li, L; Maitra, U, 2013) |
| "Atherosclerosis is an inflammatory disease in the vessel wall." | ( Han, C; Li, M; Liu, J; Mao, J; Pang, X; Song, J; Wang, S; Wu, D, 2012) |
| "Accelerated atherosclerosis is the major cause of mortality in patients on chronic hemodialysis (HD)." | ( Alp, HH; Ari, E; Asicioglu, E; Atakan, A; Demir, H; Kaspar, C; Kaya, Y; Kedrah, AE; Macunluoglu, B, 2013) |
| "Atherosclerosis is associated with lipid accumulation and inflammation in the arterial wall, and bacteria have been suggested as a causative agent of this disease." | ( Bäckhed, F; Fagerberg, B; Fåk, F; Karlsson, FH; Nielsen, J; Nookaew, I; Petranovic, D; Tremaroli, V, 2012) |
| "Atherosclerosis is a major cause of death in the Western World." | ( Delgado-Roche, L; Martínez-Sánchez, G; Re, L, 2013) |
| "Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide." | ( Murakami, S, 2014) |
| "Atherosclerosis is a chronic inflammatory disease that is based on the interaction between inflammatory cell subsets and specific cells in the arterial wall." | ( Matter, CM; Stein, S; Winnik, S, 2012) |
| "The hallmark of atherosclerosis is the accumulation of plaque in vessel walls." | ( Dellinger, A; Kepley, CL; Link, K; Olson, J; Sandros, MG; Vance, S; Yang, J; Zhou, Z, 2013) |
| "Atherosclerosis is a chronic inflammatory disease promoted by hyperlipidemia." | ( Badeau, RM; Gerdes, N; Gisterå, A; Hansson, GK; Jauhiainen, M; Ketelhuth, DF; Klingenberg, R; Lohmann, C; Lundberg, AM; Lüscher, TF; Nilsson, SK; Olivecrona, G; Rudling, M; Sparwasser, T; Strodthoff, D; Zoller, S, 2013) |
| "Atherosclerosis is a major risk factor for cardiovascular disease (CVD) and stroke." | ( Hadoke, PW; Liu, X; MacKinnon, AC; Miller, MR; Newby, DE; Sethi, T, 2013) |
| "Atherosclerosis is an inflammatory condition of the arterial wall mediated by cells of both innate and adaptive immunity." | ( Allen, RH; Delaney, C; Fernandes, C; Garg, SK; Hoeltzel, M; Stabler, S; Yung, R, 2013) |
| "Treatment of atherosclerosis is currently based on reducing risk factors, e." | ( Bult, H; Schrijvers, DM; Van Brussel, I; Van Vré, EA, 2013) |
| "Atherosclerosis is a chronic inflammatory vascular disease driven by the subendothelial accumulation of macrophages." | ( Chan, L; Corbalán-Campos, J; Hartmann, P; Heyll, K; Nazari-Jahantigh, M; Schober, A; Thiemann, A; Weber, C; Wei, Y; Zhu, M, 2013) |
| "Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain." | ( Bodholdt, RP; Hag, AM; Kjaer, A; Pedersen, SF; Ripa, RS, 2013) |
| "Atherosclerosis is responsible for the high mortality rate in end-stage renal disease patients." | ( Arikan, H; Asicioglu, E; Kahveci, A; Koc, M; Ozener, CI; Tuglular, S, 2013) |
| "Atherosclerosis is a progressive multifaceted inflammatory disease affecting large- and medium-sized arteries." | ( Blaise, S; Debelle, L; Duca, L; Gayral, S; Hornebeck, W; Laffargue, M; Maurice, P, 2013) |
| "Atherosclerosis is the major cause of mortality in the developed countries." | ( Jiang, XC; Liu, J, 2013) |
| "Premature atherosclerosis is a common complication of SLE and results in substantial morbidity and mortality from cardiovascular disease (CVD)." | ( Andry, CD; Aprahamian, T; Duffau, P; Richards, RJ; Richez, C; Rifkin, IR; Weitzner, Z, 2013) |
| "Atherosclerosis is a common disease that stems from the buildup of fatty/cholesterol plaques on the endothelial cells of arteries." | ( Mani, S; Untereiner, A; Wang, R; Wu, L, 2014) |
| "Atherosclerosis is by far the most common etiology of renal artery stenosis in elderly." | ( Jayaram, AA; Kute, VB; Madan, TH; Manjunath, AP; Rawal, JR; Shukla, AN; Udhreja, S, 2013) |
| "Although atherosclerosis is initiated by deposition of cholesterol-rich lipoproteins in the artery wall, the entry of inflammatory leukocytes into lesions fuels disease progression and impairs resolution." | ( Distel, E; Fisher, EA; Goldberg, IJ; Hu, Y; Huang, LS; Miller, RG; Murphy, AJ; Nagareddy, PR; Orchard, TJ; Ramkhelawon, B; Schmidt, AM; Stirzaker, RA; Tall, AR; Westerterp, M; Yu, S, 2013) |
| "Atherosclerosis is a major pathological process related with several important adverse vascular events including coronary artery disease, stroke, and peripheral arterial disease." | ( Buğra, Z; Çimen, A; Dalan, AB; Isbir, T; Polat, N; Toptaş, B; Yılmaz-Aydoğan, H, 2013) |
| "Spontaneous atherosclerosis is common in psittaciformes, and clinical signs associated with flow-limiting stenosis are encountered in pet birds." | ( Beaufrère, H; Clubb, S; Cray, C; Nevarez, JG; Tully, TN; Wakamatsu, N, 2013) |
| "Atherosclerosis is associated with reduced vascular hydrogen sulfide (H2 S) biosynthesis." | ( Chen, Q; Dai, W; Han, Y; Ji, Y; Li, L; Li, X; Liu, Z; Lu, H; Meng, G; Moore, PK; Pan, S; Peh, MT; Shirhan, M; Tan, CH; Wang, X; Xie, L; Zhou, S, 2013) |
| "Atherosclerosis is one of the most common causes of death and disability in the United States today despite the availability of statins, which reduce hyperlipidemia, a risk factor that predisposes individuals to this disease." | ( Sorci-Thomas, MG; Thomas, MJ, 2013) |
| "Atherosclerosis is accelerated in diabetes mellitus mainly due to the reduced availability and function of endothelial progenitor cells (EPCs)." | ( Liu, Y; Wang, X; Wang, Y; Xia, M; Zhang, Y, 2013) |
| "Atherosclerosis is a chronic disease characterized by the deposition of excessive cholesterol in the arterial intima." | ( Fu, YC; Tang, CK; Yin, K; Yu, XH; Zhang, DW, 2013) |
| "Atherosclerosis is a chronic inflammatory disorder that occurs as a result of mononuclear lymphocyte infiltration to the arterial wall, smooth muscle cell proliferation and damage in the arterial wall caused by extracellular matrix accumulation." | ( Baykal, AT; Kaga, E; Karademir, B; Ozer, NK, 2013) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall characterized by endothelial dysfunction, and in which innate and adaptive immune responses have a crucial role." | ( Businaro, R; Buttari, B; Capoano, R; Profumo, E; Riganò, R; Salvati, B; Saso, L, 2013) |
| "Atherosclerosis is an inflammatory disease of the vasculature regulated by cytokines." | ( Ashlin, TG; Kwan, AP; Ramji, DP, 2013) |
| "Atherosclerosis is characterized by the accumulation of lipids within the arterial wall and is commonly diagnosed using standard histology." | ( Brehm, BR; Cicchi, R; Dietzek, B; Lattermann, A; Matthäus, C; Meyer, T; Pavone, FS; Popp, J, 2014) |
| "Atherosclerosis is a chronic inflammatory disease involving the accumulation of monocytes and macrophages in the vascular wall." | ( Asmis, R; Kim, HS; Ullevig, S, 2013) |
| "Atherosclerosis is considered to be a chronic inflammatory disease of the arterial wall." | ( Littlefield, MJ; Reiss, AB; Voloshyna, I, 2014) |
| "Because atherosclerosis is both a lipid and an inflammatory disease, it is important to understand how inhibition of Rho/ROCK pathway could contribute to statins' antiatherosclerotic effects." | ( Liao, JK; Sawada, N, 2014) |
| "Atherosclerosis is an inflammatory disease regulated by infiltrating monocytes and T cells, among other cell types." | ( Andrés, V; Arias, CF; Barber, DF; Carrera, AC; Fuster, JJ; Hirsch, E; Pérez-Yagüe, S; Spada, R; Wymann, M; Zotes, TM, 2013) |
| "Atherosclerosis is a chronic inflammatory disease that arises from an imbalance in lipid metabolism and a maladaptive immune response driven by the accumulation of cholesterol-laden macrophages in the artery wall." | ( Fisher, EA; Moore, KJ; Sheedy, FJ, 2013) |
| "Atherosclerosis is an inflammatory disease of the vascular wall." | ( Breitbart, E; Feige, E; George, J; Harats, D; Ishai, E; Levi, I; Mendel, I; Propheta-Meiran, O; Salem, Y; Shoham, A; Yacov, N, 2014) |
| "Since atherosclerosis is an inflammatory disease, the auto-immune mediated inflammation observed in RA patients contributes to increased endothelial dysfunction, oxidative stress and activation and vascular migration of leukocytes." | ( Castro Cabezas, M; Hazes, JM; Klop, B; van Breukelen-van der Stoep, DF; van Zeben, D, 2013) |
| "Atherosclerosis is consistently higher among the HIV-positive patients, with or without treatment, than among the HIV-negative population." | ( Arnett, DK; Grunfeld, C; Irvin, MR; Shrestha, S, 2014) |
| "Atherosclerosis is a chronic vascular disease in which oxidative stress and inflammation are commonly implicated as major causative factors." | ( Favero, G; Reiter, RJ; Rezzani, R; Rodella, LF, 2014) |
| "Atherosclerosis is the pathological basis of coronary heart disease, one of the major causes of death worldwide." | ( Cayabyab, FS; Jiang, N; Tang, CK; Yao, PB; Yu, XH; Zheng, XL, 2014) |
| "Atherosclerosis is the main underlying cause of major cardiovascular diseases such as stroke and heart attack." | ( Berliner, J; Cheng, J; Gugiu, BG; Jung, ME; Koroniak, L; Lee, S; Li, R; Yan, X, 2014) |
| "Atherosclerosis is characterized by endothelial dysfunction, vascular inflammation, and the buildup of lipids, cholesterol, calcium, and cellular debris within the intima of the walls of large and medium size arteries." | ( Ajeena, IM; Hadi, NR; Mohammad, BI; Sahib, HH, 2013) |
| "Risk of atherosclerosis is marked by increase in stiffness parameters even in presence of a single MS risk and zinc deficiency may further aggravate the risk indicating need for early diagnosis." | ( Chiplonkar, S; Divate, U; Khadilkar, A; Khadilkar, V; Kinare, A; Pandit, D, 2013) |
| "Since atherosclerosis is the main pathological feature of diabetic cardiovascular complications, it is important to investigate the anti-atherosclerotic effect of sitagliptin and explore the relevant mechanisms." | ( Guan, M; He, F; Li, C; Li, J; Wang, L; Xu, W; Xue, Y; Zeng, Y; Zheng, Z, 2014) |
| "Atherosclerosis is a major macrovascular complication of diabetes that increases the risks for myocardial infarction, stroke, and other vascular diseases." | ( El-Bassossy, HM; Fahmy, A; Hassan, NA; Mahmoud, MF, 2014) |
| "Osteoporosis and atherosclerosis are the two most common diseases in postmenopausal women." | ( Igase, M; Kohara, K; Miki, T; Ochi, M; Ohara, M; Okada, Y; Tabara, Y; Takita, R, 2014) |
| "Because atherosclerosis is an inflammatory process involving a series of pathological events such as dyslipidemia, oxidative stress, and blood clotting mechanisms, we hereby report the synthesis and evaluation of novel compounds in which antioxidant, anti-inflammatory, and squalene synthase (SQS) inhibitory/hypolipidemic activities are combined in simple molecules through design." | ( Kourounakis, AP; Matralis, AN, 2014) |
| "Atherosclerosis is the most common cause of cardiovascular disease." | ( Brinkmann, O; Dietrich, T; Guski, H; Kühn, H; Linz, D; Patzak, A; Schmerbach, K; Tietge, UJ; Wilfert, K, 2014) |
| "Changes in atherosclerosis are more dynamic in patients with symptomatic ICAS, and the predictors of symptomatic and asymptomatic ICAS differ." | ( Cho, YJ; Hong, KS; Kang, DW; Kim, BJ; Kim, JS; Koo, JS; Kwon, SU; Lee, JH; Lee, SH; Park, JM, 2014) |
| "Atherosclerosis is one of the most common disorders among the elderly." | ( Abdelbary, A; Hamza, M; Unis, A, 2014) |
| "Atherosclerosis is a systemic inflammatory disease characterized by the accumulation of dendritic cells (DCs) and other types of immune cells in atherosclerotic plaque." | ( Fang, X; Guan, S; Li, W; Liao, P; Liu, L; Wang, B, 2014) |
| "Atherosclerosis is a chronic inflammatory disease due to lipid deposition in the arterial wall." | ( Busso, N; Ives, A; Kobayashi, T; Matsui, C; Nomura, J; Shirakura, T; So, A; Tamura, M; Tsujimoto, S; Yamanaka, Y, 2014) |
| "Atherosclerosis is a chronic inflammatory disease, which is associated with increased expression of adhesion molecules and monocyte recruitment into the arterial wall." | ( Byeon, HE; Koo, HJ; Kwak, JH; Kwon, ST; Park, HJ; Pyo, S; Rhee, DK; Um, SH, 2014) |
| "Atherosclerosis is the most common pathologic process underlying cardiovascular disease." | ( Chen, C; Deng, Q; Gao, H; Huang, F; Huang, Q; Xu, J; Yang, W; Zhang, L, 2014) |
| "Atherosclerosis is an aging-related disease, the pathogenesis of which involves chronic inflammation and increased oxidative stress." | ( Lee, DC; Lee, JY, 2014) |
| "Atherosclerosis is one major cause of cardiovascular diseases, the leading cause of death in industrialized countries." | ( Gu, HM; Wang, F; Zhang, DW, 2014) |
| "Atherosclerosis is a complex vascular inflammatory disease." | ( Afek, A; Arber, N; Aroch, I; Eisenberg, O; Finkelstein, A; George, J; Kazanov, D; Kraus, S; Naumov, I; Shapira, S, 2014) |
| "Atherosclerosis is a major contributor to the overall United States mortality rate, primarily in the form of heart attacks and stroke." | ( Anderson, JL; Keeley, MC; Smith, EC; Smith, SC; Taylor, RL, 2014) |
| "Atherosclerosis is the primary cause of cardiovascular diseases and stroke." | ( Chen, Y; Cui, J; Du, X; Jia, C; Wang, P; Wang, W; Xiong, M; Yang, Q; Zhang, T, 2014) |
| "Atherosclerosis is a consequence of diverse pathologies that could be affected by signaling mediated by nucleotides and their metabolites." | ( Chlopicki, S; Kutryb-Zajac, B; Lipinski, M; Rybakowska, I; Slominska, EM; Smolenski, RT; Toczek, M; Zabielska, M; Zukowska, P, 2014) |
| "Atherosclerosis is the main underlying cause of ischemic heart disease and related acute cardiovascular complications, including myocardial infarction and stroke." | ( Huynh, DN; Marleau, S; Mellal, K; Ong, H, 2014) |
| "The early stages of atherosclerosis are initiated by the accumulation of oxLDL and the induction of toxic effects on endothelial cells, resulting in endothelial dysfunction." | ( Amoêdo, ND; da Rocha, JB; de Bem, AF; de Oliveira, J; Galina, A; Hort, MA; Ribeiro-do-Valle, RM; Straliotto, MR, 2014) |
| "Atherosclerosis is a leading cause of obliterating diseases of the arteries in 80-90% of cases." | ( Khavinson, VKh; Kitachev, KV; Kozlov, KL; Petrov, KIu; Sazonov, AB; Sliusarev, AS, 2014) |
| "Because atherosclerosis is a chronic inflammatory disease driven by leukocyte recruitment to the vessel wall, we hypothesized a role of P2Y6 in atherogenesis." | ( Ayata, CK; Bode, C; Cicko, S; Dufner, B; Grimm, M; Hergeth, S; Hoppe, N; Idzko, M; Marchini, T; Michel, NA; Peikert, A; Reinöhl, J; Schulte, L; Stachon, P; von zur Muhlen, C; Wolf, D; Zirlik, A, 2014) |
| "Atherosclerosis is a chronic inflammatory disease in the vessel." | ( Liu, J; Pang, X; Wang, S; Wu, D; Zhang, X; Zhao, J, 2014) |
| "Atherosclerosis is the commonest and most important vascular disease." | ( Al Batran, R; Al-Bayaty, F; Al-Obaidi, MM; Ashrafi, A, 2014) |
| "An early sign of atherosclerosis is the accumulation of LDL-derived lipid droplets in the arterial wall." | ( Gursky, O; Lu, M, 2013) |
| "Since atherosclerosis is a preventable condition and is largely caused by accumulation of cholesterol in the arteries, the treatment of hypercholesterolemia is one of the mainstay in primary and secondary prevention." | ( Lippi, G; Mattiuzzi, C, 2014) |
| "Atherosclerosis is a multifactorial and progressive disease commonly correlated with a high fat diet." | ( Guo, J; Li, J; Li, X; Liu, Y; Wang, L; Wu, T; Yang, Y; Yuan, F; Zhang, Q; Zheng, L, 2014) |
| "Atherosclerosis is the proximate cause of arterial thrombosis, leading to acute occlusive cardiovascular syndromes." | ( Shah, PK, 2014) |
| "Atherosclerosis is the main pathophysiological process underlying acute cardiovascular diseases." | ( Carbone, F; Mach, F; Montecucco, F, 2015) |
| "Atherosclerosis is the major cause of death and disability in diabetic and obese subjects with insulin resistance." | ( Araldi, E; Aranda, JF; Aryal, B; Chamorro-Jorganes, A; Fernández-Hernando, C; Goedeke, L; Ramírez, CM; Rotllan, N; Salerno, AG; Sessa, WC; Suárez, Y; Wanschel, AC, 2015) |
| "Atherosclerosis is considered as an inflammatory disease, and carotid artery intima-media thickness (IMT) and carotid plaque are generally used as intermediated phenotype of atherosclerosis." | ( Cho, HC; Chung, IS; Chung, JH; Jun, SE; Park, KO; Shin, DH; Yu, GI, 2015) |
| "Atherosclerosis is the complex lesion that consists of endothelial inflammation, macrophage foam cell formation, vascular smooth muscle cell (VSMC) migration and proliferation, and extracellular matrix production." | ( Hasegawa, A; Hirano, T; Nohtomi, K; Sato, K; Shirai, R; Watanabe, K; Watanabe, R; Watanabe, T; Yamamoto, K, 2014) |
| "Atherosclerosis is a chronic multifactorial disease of the arterial wall characterized by endothelial dysfunction, inflammation and oxidative stress." | ( Buttari, B; Profumo, E; Rigano, R; Saso, L, 2014) |
| "We propose that atherosclerosis is associated with reduced ACE2 expression in heart and kidney." | ( Karpe, PA; Kumar, S; Malek, V; Patel, G; Sanghavi, M; Srinivasan, K; Tikoo, K, 2015) |
| "Atherosclerosis is a multifactorial disease mainly caused by deposition of low-density lipoprotein (LD) cholesterol in macrophages of arterial walls." | ( Daglia, M; Mansouri, K; Nabavi, SF; Nabavi, SM; Orhan, IE; Tenore, GC, 2015) |
| "Atherosclerosis is essentially a vascular inflammatory process in the presence of an excess amount of lipid." | ( Hara, T; Ihara, K; Kanno, S; Kono, H; Motomura, Y; Murata, K; Nishio, H; Onimaru, M; Sueishi, K; Tanaka, T; Yamasaki, S, 2015) |
| "Atherosclerosis is understood to be a blood vessel inflammation." | ( Ishibashi, T; Nakamura, Y; Ohkawara, H; Sugimoto, K; Takeishi, Y; Takuwa, Y, 2014) |
| "Atherosclerosis is a systemic process associated with arterial calcification in multiple vascular beds." | ( Al Garaty, F; Al-Mosawi, AA; Al-Nafakh, HA; Nafakhi, H, 2015) |
| "Atherosclerosis is a continuous pathological process that starts early in life and progresses frequently to unstable plaques." | ( Bobryshev, YV; Chistiakov, DA; Orekhov, AN, 2015) |
| "The progression of atherosclerosis is favored by increasing amounts of chondroitin sulfate proteoglycans in the artery wall." | ( Alfonso, Y; Batlle, F; Brito, V; Frómeta, M; Griñán, T; Mesa, N; Olivera, A; Pérez, A; Pino, A; Soto, Y; Vázquez, AM; Viera, J; Zayas, F, 2014) |
| "Atherosclerosis is a common condition that increases the risk of stroke." | ( Yang, L; Zhang, L, 2014) |
| "Atherosclerosis is a sustained inflammatory disease of the arterial wall." | ( Chen, H; Du, X; Hu, N; Kong, L; Li, C; Li, X; Meng, Q; Qian, A; Yu, X, 2015) |
| "Atherosclerosis is an inflammatory disease with the most common pathologic process leading to cardiovascular diseases." | ( Cao, Q; Fu, P; Jiang, Y; Liu, X; Niu, T; Shi, J; Xu, C; Yang, T, 2015) |
| "Atherosclerosis is the major precursor of cardiovascular disease." | ( Addadi, L; Fargion, I; Leiserowitz, L; Varsano, N; Wolf, SG, 2015) |
| "Atherosclerosis is a chronic, progressive, multifocal disease of the arterial wall, which is mainly fuelled by local and systemic inflammation, often resulting in acute ischemic events following plaque rupture and vessel occlusion." | ( Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM, 2015) |
| "Atherosclerosis is a major cause of cardiac events and mortality in patients suffering from chronic kidney disease (CKD)." | ( Figlerowicz, M; Formanowicz, D; Luczak, M; Marczak, Ł; Pawliczak, E; Stobiecki, M; Wanic-Kossowska, M, 2015) |
| "Atherosclerosis is a chronic inflammatory disease that is initiated by the retention and accumulation of low-density lipoprotein in the artery, leading to maladaptive response of cells from the immune system and vessel wall." | ( Agardh, H; Assinger, A; Bäck, M; Baumgartner, R; Berg, M; Gisterå, A; Hansson, GK; Ketelhuth, DF; Laguna-Fernandez, A; Ovchinnikova, O; Pirault, J; Polyzos, KA, 2015) |
| "Atherosclerosis is an inflammatory process that involves activation of matrix metalloproteinases (MMPs); MMPs degrade collagen and allow for smooth-muscle cell migration within a vessel." | ( Givimani, S; Neamtu, D; Rehman, S; Tyagi, SC; Vacek, TP; Yu, S, 2015) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the infiltration of pro-inflammatory macrophages into a lipid-laden plaque." | ( Casagrande, V; Federici, M; Kappel, B; Marino, A; Mavilio, M; Melino, G; Menghini, R; Möllmann, J; Stöhr, R, 2015) |
| "Atherosclerosis is characterised by the accumulation of lipids within macrophages in the artery wall." | ( Brown, BE; Croft, KD; Davies, MJ; Hawkins, CL; Ismael, FO; Proudfoot, JM; van Reyk, DM, 2015) |
| "Atherosclerosis is a common cardiovascular disease that involves the build-up of plaque on the inner walls of the arteries." | ( Li, Y; Peng, G; Qin, J; Sun, L; Wang, J; Xie, S; Zhong, D, 2015) |
| "Atherosclerosis is a common and serious vascular disease predisposing individuals to myocardial infarction and stroke." | ( Bedja, D; Chatterjee, S; Foss, CA; Kass, DA; Mease, RC; Pomper, MG; Wang, H, 2015) |
| "Atherosclerosis is in vivo pathology of individual cells unable to incorporate PFA and a syndrome of ω-3 and ω-6 PFA deficiency." | ( Titov, VN, 2014) |
| "Atherosclerosis is present in hyperlipidemic bones and valves as characterized by macrophage and osteoclast infiltration, and it is attenuated by atorvastatin, which may have implications for therapy in the future." | ( Rajamannan, NM, 2015) |
| "Atherosclerosis is now generally accepted as a chronic inflammatory condition." | ( Chandrasekaran, B; Jayachandran, M; Namasivayam, N, 2015) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the activation of some components of the cyclooxygenase pathway." | ( Gautier-Veyret, E; Lévy, P; Pepin, JL; Stanke-Labesque, F; Van Noolen, L, 2015) |
| "Atherosclerosis is a multifactorial condition characterized by endothelial injury, fatty streak deposition, and stiffening of the blood vessels." | ( Priyadharsini, RP, 2015) |
| "Accelerated atherosclerosis is a major cause of morbidity and death in SLE." | ( Bathon, JM; Kiani, AN; Magder, LS; O'Leary, D; Petri, M; Post, WS; Schreiner, PJ; Szklo, M, 2015) |
| "Th1 responses in atherosclerosis are mainly associated with the aggravation of atherosclerotic plaques, whereas Th2 responses lead to a less pronounced disease in mouse models." | ( Esposito, B; Laurans, L; Mallat, Z; Ponnuswamy, P; Steinmetz, M; Tedgui, A, 2015) |
| "Atherosclerosis is considered to be a systemic vascular inflammatory disease, and oxidative stress is known to be a contributor to vascular inflammation." | ( Ito, H; Koyama, T; Watanabe, H, 2016) |
| "Atherosclerosis is believed to be an independent predictor of cardiovascular diseases." | ( Chan, SH; Chu, PM; Hung, CH; Tsai, KL, 2015) |
| "Atherosclerosis is considered a chronic inflammatory disease and an intervention targeting the inflammatory process could be a new therapeutic strategy for preventing atherosclerotic cardiovascular diseases (CVD)." | ( Emoto, T; Hirata, K; Kasahara, K; Kitano, N; Matsumoto, T; Mizoguchi, T; Sasaki, N; Yamashita, T, 2015) |
| "Accelerated atherosclerosis is the main underlying factor contributing to the high risk of atherothrombotic events in patients with diabetes mellitus and atherothrombotic complications are the main cause of mortality." | ( Pretorius, E; Soma, P, 2015) |
| "Atherosclerosis is a chronic inflammatory response of the arterial wall to pro‑atherosclerotic factors." | ( Liu, J; Lu, P; Pang, X, 2015) |
| "Regression of atherosclerosis is mediated in part by the Liver X Receptor (LXR) through the induction of genes involved in cholesterol transport and efflux." | ( Barrett, TJ; Fisher, EA; Garabedian, MJ; Hérault, Y; Hussein, MA; Leone, S; Moore, KJ; Ouimet, M; Shrestha, E, 2015) |
| "Atherosclerosis is a chronic inflammatory disease of large and medium-sized arteries and the underlying cause of cardiovascular disease, a major cause of mortality worldwide." | ( Cardelli, JA; Green, JM; Navratil, AR; Orr, AW; Sorci-Thomas, MG; Thomas, MJ; Vozenilek, AE; Woolard, MD, 2015) |
| "Atherosclerosis is the major cause of cardiovascular disease." | ( Haller, V; Ritsch, A; Zhao, W, 2015) |
| "Atherosclerosis is a progressive inflammatory disease that can lead to sudden cardiac events by plaque rupture and subsequent thrombosis." | ( Chen, L; Ma, G; Wang, X; Zhou, Q; Zuo, P; Zuo, Z, 2015) |
| "Atherosclerosis is one of the major cause of mortality in developed countries." | ( Kazemian, MR; Seifalian, AM; Solouk, A; Tan, A, 2015) |
| "Atherosclerosis is associated with dysfunction of endothelial progenitor cells (EPCs)." | ( Cao, C; Li, M; Lu, C; Pei, E; Tang, T; Uzan, G; Wang, S; Xu, J; Ye, M; Yu, X; Zhang, X; Zhi, K; Zuo, K, 2015) |
| "Atherosclerosis is a chronic inflammatory disease with deposition of excessive cholesterol in the arterial intima." | ( Tang, CK; Yu, XH; Zheng, XL, 2015) |
| "Atherosclerosis is a chronicinflammatory condition that begins with the formation of calcified plaque, influenced by a number of different factors inside the vascular wall in large and mid-sized arteries." | ( Deftereos, S; Kalampogias, A; Mourouzis, K; Oikonomou, E; Siasos, G; Stefanadis, C; Tousoulis, D; Tsalamandris, S; Tsigkou, V; Vavuranakis, M; Zografos, T, 2016) |
| "Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide." | ( Astola, N; Cole, JE; Cribbs, AP; Davies, AH; Feldmann, M; Goddard, ME; Green, P; Monaco, C; Park, I; Williams, RO, 2015) |
| "Atherosclerosis is an autoimmune inflammatory disease involving both innate and adaptive immune mechanisms." | ( Liu, Y; Mao, X; Shi, H; Tang, H; Wang, X; Yu, K; Zeng, Q; Zhao, XI; Zhong, Y; Zhu, R, 2016) |
| "Atherosclerosis is associated with reduced mononuclear cell (MNC) telomere length, and senescent cells have been detected in atherosclerotic plaques." | ( Alvarez de Sotomayor, M; Herrera, MD; Laufs, U; Perez-Ternero, C; Werner, C, 2017) |
| "Atherosclerosis is frequently caused by clot blockage of the coronary or peripheral arteries, and may lead to myocardial infarction (MI) or peripheral arterial disease (PAD)." | ( Wang, A, 2015) |
| "Atherosclerosis is one of the leading causes of death in Japan." | ( Fujii, S, 2015) |
| "As atherosclerosis is characterized by a hypercoagulable state indicating the involvement of activated coagulation factors in the genesis of atherosclerosis, anticoagulation could have beneficial effects on atherosclerosis." | ( Schurgers, LJ; van Gorp, RH, 2015) |
| "Atherosclerosis is a major cause of death for mankind." | ( Akerele, OA; Cheema, SK, 2015) |
| "Atherosclerosis is the most common cause of cardiovascular diseases worldwide." | ( Huang, F; Peng, D; Yi, Y; Yin, J; Yin, L, 2016) |
| "Risk of subclinical atherosclerosis is increased in patients with systemic lupus erythematosus (SLE)." | ( Dhir, V; Prakash, M; Rathi, M; Sahoo, S; Sharma, SK; Singh, S, 2016) |
| "Atherosclerosis is an inflammatory condition with calcification apparent late in the disease process." | ( Abt, M; Bucerius, J; Fayad, ZA; Joshi, FR; Kallend, D; Mani, V; Rajani, NK; Rudd, JH; Tawakol, A; Woodward, M, 2016) |
| "Atherosclerosis is an inflammatory disease that affects the arterial wall leading to myocardial, cerebral, and peripheral ischemic syndromes." | ( Beutler, H; Brusco, I; de Almeida, AS; de Oliveira, SM; Duarte, MM; Duarte, T; Hirsch, GE; Klafke, JZ; Nascimento, S; Parisi, MM; Pereira, RL; Porto, FG; Rubin, FH; Schmidt, A; Trevisan, G; Viecili, PR, 2016) |
| "Atherosclerosis is inherently an inflammatory process that is strongly affected by the chemokine-chemokine receptor axes regulating the trafficking of inflammatory cells at all stages of the disease." | ( Detering, L; Fors, BP; Gropler, RJ; Hawker, CJ; Liu, Y; Luehmann, HP; Pressly, ED; Randolph, GJ; Woodard, PK, 2016) |
| "Models of atherosclerosis are used in preclinical studies but often fail to translate to humans." | ( Amuzie, C; Denham, S; Mais, DE; Rogers, CS; Swart, JR; Vihtelic, T, 2016) |
| "Atherosclerosis is a leading cause of vascular disease worldwide." | ( Armitage, J; Herrington, W; Lacey, B; Lewington, S; Sherliker, P, 2016) |
| "Therapies for atherosclerosis are challenged by a lack of targeted drug delivery approaches." | ( Czech, T; Ganguly, R; Myer, AB; Raman, P; Sahu, S; Steinmetz, NF; Wen, AM, 2016) |
| "Atherosclerosis is the underlying cause of cardiovascular disease that leads to more global mortalities each year than any other ailment." | ( Davies, TS; Garaiova, I; Michael, DR; Moss, JW; Plummer, SF; Ramji, DP, 2016) |
| "Atherosclerosis is universally recognized as a chronic lipid-induced inflammation of the vessel wall in response to dyslipidemia and haemodynamic stress involving dysfunction and activation of resident vascular cells as well as infiltration of leukocytes." | ( Ding, JW; Wang, XA; Zheng, XX; Zhou, T, 2016) |
| "Progression of atherosclerosis is associated with a greater risk for adverse outcomes." | ( Alkhoder, A; Binongo, JN; Dhawan, SS; Jones, DP; Oshinski, JN; Quyyumi, AA; Ramadan, R, 2016) |
| "Atherosclerosis is a lipid-driven inflammatory disease, for which nanomedicinal interventions are under evaluation." | ( Alaarg, A; Dallinga-Thie, GM; de Winther, M; Hamers, AA; Laudes, M; Lutgens, E; Meiler, S; Metselaar, JM; Mulder, WJ; Schulte, DM; Seijkens, T; Stroes, ES; Tang, J; Van den Bossche, J; van der Valk, FM; Zheng, KH, 2016) |
| "Atherosclerosis is an inflammatory disease linked to elevated blood cholesterol concentrations." | ( Bakke, SS; Björkhem, I; Bode, N; De Nardo, D; Espevik, T; Fitzgerald, ML; Grebe, A; Gustafsson, JÅ; Halvorsen, B; Hawxhurst, V; Hempel, C; Heneka, MT; Kerksiek, A; Labzin, LI; Latz, E; Lütjohann, D; Nickenig, G; Schultze, JL; Skjelland, M; Tall, AR; Trebicka, J; Ulas, T; Westerterp, M; Wright, SD; Zimmer, S, 2016) |
| "Atherosclerosis is both a chronic inflammatory disease and a lipid metabolism disorder." | ( Baquero, KC; Choudhury, M; de la Houssaye, BA; Friedman, JE; Janssen, RC; Miyazaki, M; Miyazaki-Anzai, S; Moustaid-Moussa, N; Rahman, SM; Sun, M; Wang, S, 2016) |
| "Atherosclerosis is characterized by lipid accumulation and chronic inflammation in the arterial wall." | ( Colin, S; Duplan, I; Hennuyer, N; Lefebvre, P; Lestavel, S; Paquet, C; Staels, B; Touche, V; Vallez, E; Vanhoutte, J; Woitrain, E, 2016) |
| "Atherosclerosis is a chronic inflammatory disease of the vascular walls." | ( Feng, H; Li, Y; Li, Z; Shen, B; Shi, L; Tian, Y; Zhao, C, 2016) |
| "Although atherosclerosis is treatable with lipid-lowering drugs, not all patients respond." | ( Larrick, JW; Mendelsohn, AR, 2016) |
| "Atherosclerosis is a specific form of an artery wall thickens, a syndrome affecting arterial blood vessels due to a chronic inflammatory response in the walls of arteries, which is promoted by fat accumulation." | ( Zhang, Y, 2016) |
| "Atherosclerosis is a chronic inflammatory disease and represents the leading cause of morbidity and mortality throughout the world." | ( Gao, JJ; Guo, FX; Hu, YW; Huang, C; Kang, CM; Li, P; Lu, JB; Ma, X; Qiu, YR; Sha, YH; Wang, Q; Wang, YC; Xiu, JC; Xu, BM; Zhang, Y; Zhao, JJ; Zheng, L, 2016) |
| "Atherosclerosis is a fundamental pathological process responded to some serious cardiovascular events." | ( Bao, L; Dou, Y; Jia, Y; Li, X; Li, Z; Liu, Y; Tang, Y; Zhang, J; Zheng, Y; Zhou, J; Zhou, L, 2016) |
| "Atherosclerosis is a chronic inflammatory disease driven primarily by a continuous retention of cholesterol within the subendothelial space where it precipitates to form cholesterol crystals (CC)." | ( Bode, N; Grebe, A; Kerksiek, A; Latz, E; Lütjohann, D; Nickenig, G; Werner, N; Zimmer, S, 2016) |
| "Atherosclerosis is a chronic inflammatory vascular disease related to macrophages uptake of low-density lipoprotein and their subsequent transformation into foam cells." | ( Chai, R; Fang, S; He, Z; Li, H; Li, J; Li, Z; Lin, P; Liu, F; Liu, X; Pei, C; Sun, B; Tian, J; Xu, H; Xu, Y; Yang, S; Yu, B; Zhang, T; Zhang, Y, 2016) |
| "Atherosclerosis is featured as artery wall thickness as a result of invasion and accumulation of white blood cells and proliferation of intimal smooth muscle cells." | ( Gao, XG; Li, Y; Liu, G, 2016) |
| "Atherosclerosis is the most common cause of cardiovascular diseases, such as myocardial infarction and stroke." | ( Gao, F; Gui, Y; Hu, L; Li, H; Wang, Y; Xi, C; Yan, H; Yao, S; Ye, Y; Yu, C, 2016) |
| "Atherosclerosis is a common pathological basis of cardiovascular disease, which remains the leading cause of mortality." | ( Gao, JJ; Guo, FX; Hu, YW; Huang, C; Kang, CM; Li, P; Lu, JB; Ma, X; Sha, YH; Wang, Q; Wang, YC; Xiu, JC; Xu, BM; Zhang, Y; Zhao, JJ; Zheng, L, 2016) |
| "Atherosclerosis is a chronic inflammation associated with increased expression of the acute phase isoforms of serum amyloid A (SAA) and in humans is a plasma biomarker for future cardiovascular events." | ( Getz, GS; Krishack, PA; Reardon, CA, 2016) |
| "Atherosclerosis is a leading cause of death globally." | ( Cui, Z; Li, W; Qi, M; Sun, X; Zhang, X; Zhang, XE; Zhang, Z, 2016) |
| "Atherosclerosis is a complex disorder with a multifactorial pathogenesis." | ( Abdalla, DSP; Araújo, SMDR; de Lima, IT; Gomes, FODS; Lima, MDCA; Oliveira, AC; Oliveira, AGV; Peixoto, CA; Pitta, IDR; Ribeiro, EL; Rudnicki, M; Santos Silva, BD; Silva, AKSE, 2016) |
| "Atherosclerosis is considered to be a form of chronic inflammation and a disorder of lipid metabolism." | ( Chan, SH; Cheng, YH; Chu, PM; Hung, CH; Lin, HC; Shih, JY; Tsai, KL; Tsai, YJ, 2016) |
| "Atherosclerosis is a chronic inflammatory disease of medium and large vessels and is typically characterized by the predominant accumulation of low-density lipoprotein (LDL)-cholesterol inside macrophages that reside in the vessel walls." | ( Binder, CJ; Donners, MMPC; Gijbels, MJJ; Hendrikx, T; Houben, T; Jeurissen, MLJ; Li, J; Oligschlaeger, Y; Shiri-Sverdlov, R; van Gorp, PJ; Walenbergh, SMA, 2016) |
| "Atherosclerosis is a chronic inflammatory disorder whose development is inversely correlated with high-density lipoprotein concentration." | ( Bluemn, T; Brzoza-Lewis, KL; Fulp, BE; Gerelus, M; James, R; Kallinger, R; Kaul, S; Maruko, E; Sorci-Thomas, MG; Thomas, MJ; Weerasekera, R; Xu, H; Zabalawi, M; Zhang, YS, 2016) |
| "Atherosclerosis is the main cause of death in men and women." | ( Fadiel, A; Mehr, H; Naftolin, F, 2016) |
| "Atherosclerosis is a serious public health concern." | ( Bai, L; Chen, Y; Cheng, X; Fan, J; Lin, Y; Liu, E; Wang, R; Xu, L; Yang, X; Zhang, Y; Zhao, S, 2016) |
| "Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder." | ( Ai, M; Kanda, E; Maeda, Y; Okazaki, M; Yoshida, M, 2016) |
| "The development of atherosclerosis is closely related to excessive endoplasmic reticulum stress (ERs)." | ( Hu, Q; Mi, M; Qin, L; Shi, L; Zhang, Q; Zhang, T, 2016) |
| "Atherosclerosis is an important predictor of mortality in patients with chronic kidney disease (CKD) and is associated with a wide inflammatory response." | ( Florens, N; Juillard, L; Lambert, C; Malard, B, 2017) |
| "Atherosclerosis is a progressive and multifactorial disease which occurs under the influence of various risk factors including endothelial dysfunction (ED), oxidative stress, and low-density lipoprotein (LDL) oxidation." | ( Hoseini, Z; Mirzaei, H; Rashidi, B; Sahebkar, A, 2017) |
| "Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries." | ( Doroudchi, M; Hosseini, A; Khosropanah, S; Yazdani, M, 2016) |
| "Atherosclerosis is characterized by endothelial dysfunction, mainly induced by inflammation and oxidative stress." | ( Buttari, B; D'Arcangelo, D; Delogu, G; Dettori, MA; Fabbri, D; Profumo, E; Riganò, R; Tinaburri, L, 2016) |
| "Atherosclerosis is characterized by a chronic non-resolving inflammation in the arterial wall." | ( Arnardottir, H; Bäck, M; Hansson, GK; Laguna-Fernandez, A; Perretti, M; Petri, MH; Wheelock, CE, 2017) |
| "Accelerated atherosclerosis is related to traditional (age, hypertension, diabetes mellitus, dyslipidemia, obesity, smoking, and positive family history) and non-traditional, disease-related factors." | ( Kiss, E; Szabó, MZ; Szodoray, P, 2017) |
| "Atherosclerosis is known to be the primary underlying factor responsible for the development of cardiovascular diseases." | ( An, Y; Fang, W; Ma, A; Wang, D; Zhu, H, 2017) |
| "Atherosclerosis is characterized by a proliferation of vascular smooth muscle cells (VSMCs) and their migration to the intima, which induces thickening of the intima itself, but the mechanism remains poorly understood." | ( Artico, M; Bonomini, F; Parnigotto, P; Rezzani, R; Rodella, LF; Taurone, S; Zamai, L, 2016) |
| "Although atherosclerosis is described in New Zealand White rabbit's iliac artery, yet details of time-dependent atherosclerosis progression are not well known." | ( Barthwal, MK; Dikshit, M; Farooqui, M; Jain, M; Kanshana, JS; Khanna, V; Kumar, S; Misra, A; Singh, V, 2017) |
| "Pathogenesis of atherosclerosis is characterized by the proliferation and migration of vascular smooth muscle cells (VSMCs) and inflammatory lesions." | ( He, Z; Li, W; Liu, F; Niu, X; Wang, X; Zhi, W, 2017) |
| "Atherosclerosis is a chronic inflammatory process of vessel walls responsible for coronary, cerebrovascular and peripheral vascular disease, which together account for the majority of non-infective global deaths." | ( Baerlecken, NT; Bengel, FM; Daehnrich, C; Derlin, T; Ernst, D; Schlumberger, W; Schmidt, RE; Weiberg, D; Witte, T, 2017) |
| "The pathogenesis of atherosclerosis is associated with endothelial dysfunction." | ( Biegańska-Hensoldt, S; Rosołowska-Huszcz, D, 2017) |
| "Atherosclerosis is a chronic fibroproliferative inflammatory process and iron, through increased oxidation stress as well as directly, can control both native and adaptive immune responses." | ( Kraml, P, 2017) |
| "Atherosclerosis is a disease in which atheromatous plaques develop inside arteries, leading to reduced or obstructed blood flow that in turn may cause stroke and heart attack." | ( Axling, U; Cavalera, M; Holm, C; Rippe, C; Swärd, K, 2017) |
| "Atherosclerosis is a common cardiovascular disease that causes myocardial infarction, heart failure, and stroke." | ( Liu, C; Wang, Y; Yao, Y; Zhang, Y, 2017) |
| "Atherosclerosis is the major cause of cardiovascular disease; hypercholesterolemia is a major risk factor." | ( Aravanis, CV; Cokkinos, DV; Giaglis, S; Kapelouzou, A; Karayannakos, PE; Katsimpoulas, M; Kostakis, A; Moustardas, P; Peroulis, M, 2017) |
| "A hallmark of early atherosclerosis is the uptake of oxidized low density lipoprotein (oxLDL) by macrophages, which results in foam cell and plaque formation in the arterial wall." | ( Abdelhamid, DS; Chmielowski, RA; Faig, JJ; Gardner, CR; Joseph, LB; Moghe, PV; Petersen, LK; Uhrich, KE, 2017) |
| "Atherosclerosis is a chronic disease that can seriously endanger human life." | ( Cui, S; Gao, Y; Huang, G; Li, W; Lv, X; Wang, P, 2017) |
| "Atherosclerosis is a pathological process underpinning many cardiovascular diseases; it is the main cause of global mortality." | ( Siltari, A; Vapaatalo, H, 2018) |
| "Atherosclerosis is an important pathological condition which is accompanied by a vascular smooth muscle cell (VSMC) phenotype switch toward a synthetic phenotype." | ( Chen, J; Wang, S; Zhang, X, 2017) |
| "Atherosclerosis is a disease caused by a build-up of fatty plaques and cholesterol in the arteries." | ( Csernoch, L; Fodor, J; Gomba-Tóth, A; Ioannis, I; Kovács, I; Molnár, B; Oláh, T; Tóth, ZC; Zádor, E, 2017) |
| "Atherosclerosis is a progressive, chronic inflammation in artery walls." | ( Chabowski, A; Choromańska, B; Choromańska, K; Dadan, J; Myśliwiec, P, 2017) |
| "Atherosclerosis is a major cause of mortality and morbidity, which is mainly driven by complications such as myocardial infarction and stroke." | ( Chen, YC; Elgass, KD; Htun, NM; Huang, AL; Lim, B; Maghzal, GJ; Peter, K; Rivera, J; Schiller, T; Schneider, HG; Stocker, R; Wood, BR, 2017) |
| "The pathogenesis of atherosclerosis is still unclear in this group of patients." | ( Arczyńska, K; Barska, K; Karczewski, M; Knysz, B; Kwiatkowska, W; Witkiewicz, W, 2017) |
| "Atherosclerosis is an inflammatory disease in which dysfunction of mitochondria play an important role, and disorders of lipid management intensify this process." | ( Gajda, M; Gębska, A; Jawień, J; Korbut, R; Kuś, K; Olszanecki, R; Stachowicz, A; Suski, M; Totoń-Żurańska, J; Wiśniewska, A, 2017) |
| "Atherosclerosis is a systemic disease, with meaningful morbidity and mortality when present in the coronary, cerebral, or major peripheral arteries." | ( Dobesh, PP; Patel, M, 2017) |
| "Calcific atherosclerosis is a major challenge to intraluminal drug delivery in peripheral artery disease (PAD)." | ( Edelman, ER; Garcia-Polite, F; Knutson, J; Kohler, R; Markham, P; Muraj, B; Nikanorov, A; Stanley, J; Tzafriri, AR; Zani, B, 2017) |
| "Atherosclerosis is the most common cause of cardiovascular disease, such as myocardial infarction and stroke." | ( Chen, LY; Cheng, HP; Gong, D; Huang, C; Li, L; Ou, X; Pan, YJ; Tan, RQ; Tang, CK; Tian, GP; Xia, XD; Xie, W; Yang, FY; Ye, Q; Yu, XH; Zhang, J; Zhang, M; Zhang, X; Zhao, ZW; Zheng, XL, 2018) |
| "Atherosclerosis is one of the diseases related to metabolic syndrome which is caused by obesity." | ( Gao, Y; Kawai, Y; Liu, L; Matsushima, Y; Nagai, I; Sayama, K, 2017) |
| "Atherosclerosis is a chronic inflammatory disease of the artery wall where both innate and adaptive immunity play important roles." | ( Demetz, E; Dietrich, H; Onestingel, E; Wick, C; Wick, G, 2018) |
| "Atherosclerosis is a chronic inflammatory disease that is promoted, among others, by pro-inflammatory cytokines such as IL-1β and IL-18 produced by NLRP 3 inflammasome." | ( Agrogiannis, G; Androutsopoulou, V; Dontas, IA; Iliopoulos, DC; Kaminiotis, VV; Konstantopoulos, P; Korou, LM; Perrea, D; Vlachos, IS, 2017) |
| "Atherosclerosis is the major pathological process behind this epidemic." | ( Drozdz, K; Dziegiel, P; Mlynarz, P; Paslawska, U; Paslawski, R; Podhorska, M; Polakof, S; Szuba, A; Wojtowicz, W; Zabek, A, 2017) |
| "Atherosclerosis is a chronic inflammatory artery disease." | ( Aurich, F; Eckstein, N; Nickenig, G; Pingel, S; Pizarro, C; Schaefer, C; Schahab, N; Schueler, R; Skowasch, D; Tuleta, I, 2017) |
| "Atherosclerosis is a chronic inflammatory disease, which is thought to be one of the most common causes of death globally." | ( Guo, D; Tan, Y; Wang, J; Yuan, X; Yuan, Z; Zhang, H, 2017) |
| "Atherosclerosis is an age-associated disease; however, diabetic atherosclerosis has higher severity beyond age range for accumulative premature senescent cells in diabetes." | ( Huang, S; Li, Y; Qin, R; Wang, F; Wang, Z; Yan, H; Zhang, W; Zhang, Y; Zhong, M, 2018) |
| "Atherosclerosis is a focal disease occurring at arterial sites of disturbed blood flow that generates low oscillating shear stress." | ( Bowden, NP; Evans, PC; Green, JP; Martinez-Campesino, L; Souilhol, C; Wilson, HL; Xanthis, I, 2018) |
| "Atherosclerosis is a multifactorial process." | ( Abu-Saleh, N; Hamoud, S; Hassan, A; Hayek, T; Shekh Muhammad, R; Zohar, Y, 2017) |
| "The progression of atherosclerosis is linked to proliferation and migration of vascular smooth muscle cell via MMP-2 and MMP-9 activities." | ( Cherng, JY; Liu, CC; Pan, KH; Shen, CR; Shih, MF, 2018) |
| "Atherosclerosis is a chronic inflammatory disease of the arteries." | ( Ailanen, L; Nuutinen, S; Rinne, P; Savontaus, E, 2018) |
| "Atherosclerosis is an autoimmune disease caused by self- and non-self-antigens contributing to excessive activation of T and B cell immune responses." | ( Feng, WJ; Guo, BB; Li, YK; Liu, Q; Mo, ZC; Ou, HX; Yang, Z, 2018) |
| "Atherosclerosis is considered a chronic inflammatory disease of the arterial wall." | ( Celermajer, DS; Martínez, GJ; Patel, S, 2018) |
| "Atherosclerosis is characterized by chronic inflammation in vascular wall." | ( Cao, W; Li, XQ; Liu, XX; Ma, WL; Mo, D; Sun, Y; Wang, K; Wang, XY; Zhang, XW, 2018) |
| "Atherosclerosis is characterised by the infiltration of macrophages at sites of inflammation within the vessel wall and the release of myeloperoxidase (MPO), which forms hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN)." | ( Hawkins, CL; Pan, GJ; Rayner, BS; van Reyk, DM; Zhang, Y, 2018) |
| "Atherosclerosis is a progressive disease of large arteries and a leading cause of cardiovascular diseases and stroke." | ( Bhatt, LK; Johnston, TP; Solanki, A, 2018) |
| "Atherosclerosis is one of the potential risk factors in hypertensive patients with epistaxis." | ( Bazak, R; Elwany, S; Ibrahim, AA; Ibrahim, HA; Soliman, AI, 2018) |
| "Atherosclerosis is an inflammatory disorder of the arterial wall, in which several players contribute to the onset and progression of the disease." | ( Bonacina, F; Catapano, AL; Norata, GD; Pirillo, A, 2018) |
| "Atherosclerosis is a chronic disease characterized by excess cholesterol deposition in the arterial intima and the formation of foam cells." | ( Chamani, E; Fallah, S; Kazemi, T; Sargolzaei, J; Soori, H, 2018) |
| "Atherosclerosis is a common disease seriously detrimental to human health." | ( Li, W; Li, Y; Lian, N; Tong, J; Wu, J, 2018) |
| "Atherosclerosis is a progressive disease of large arteries characterized with chronic inflammation and aberrant immune response." | ( Chen, H; Ji, WJ; Li, T; Li, X; Li, YX; Ma, YQ; Wang, W; Zhao, JH; Zhou, X, 2018) |
| "Atherosclerosis is the main underlying causes of cardiovascular disease." | ( Folestad, E; Länne, T; Rossignoli, A; Skogberg, J; Vorkapic, E; Wågsäter, D; Wanhainen, A, 2018) |
| "As atherosclerosis is accelerated both by hyperlipidemia and inflammation, we aim to determine the effect of dietary MOS on atherosclerosis development in hyperlipidemic ApoE*3-Leiden." | ( Giera, M; Heijink, M; Hoving, LR; Katiraei, S; Pronk, A; Streefland, T; van der Wee-Pals, L; van Harmelen, V; Willems van Dijk, K, 2018) |
| "Myocarditis and atherosclerosis are two inflammatory and autoimmune cardiovascular diseases that cause important adverse circulatory events." | ( Benitez, R; Caro, M; Delgado, M; Delgado-Maroto, V; Duran-Prado, M; Forte-Lago, I; Gonzalez-Rey, E; Lichtman, AH; O'Valle, F, 2018) |
| "Atherosclerosis is identified as the formation of atherosclerotic plaques, which could initiate the formation of a blood clot in which its growth to coronary artery can lead to a heart attack." | ( Fattahi, A; Jodati, AR; Latifi, Z; Mihanfar, A; Nejabati, HR; Nouri, M; Pezeshkian, M; Safaie, N; Valiloo, M, 2018) |
| "Atherosclerosis is a chronic multifactorial and inflammatory disease of large and medium arteries and the leading cause of cardiovascular diseases worldwide." | ( Alayrac, P; Augé, N; Coste, A; Geoffre, N; Grazide, MH; Lallemand, T; Nègre-Salvayre, A; Recazens, E; Rouahi, M; Salvayre, R; Swiader, A, 2018) |
| "Atherosclerosis is driven by an inflammatory milieu in the walls of artery vessels." | ( Amrein, MW; Chen, J; Fan, Y; Ma, X; Shi, Y; Shu, F; Xia, T; Yu, L; Zheng, W, 2018) |
| "Diseases caused by atherosclerosis are the leading causes of death in postmenopausal women, owing to the loss of estradiol." | ( Liu, P; Shen, D; Shen, T; Sun, H; Tian, L, 2018) |
| "The development of atherosclerosis is accompanied by escalating inflammation and lipid accumulation within blood vessel walls." | ( Jiang, T; Liang, Y; Ren, K; Zhao, GJ; Zhou, HF, 2018) |
| "Atherosclerosis is a chronic condition associated with cardiovascular disease." | ( Cummins, CL; Rasheed, A, 2018) |
| "Atherosclerosis is a leading cause of vascular diseases worldwide." | ( An, H; Dou, Y; Hu, H; Jia, Y; Li, L; Lu, S; Tao, H; Wang, Y; Xu, X; Zhang, J; Zhao, W, 2018) |
| "Atherosclerosis is widely known to be a chronic inflammatory disease." | ( Chen, L; Li, D; Long, L; Lu, S; Mao, J; Xu, S; Yao, Y; Zhao, L, 2019) |
| "Atherosclerosis is the leading cause of death worldwide." | ( Buszko, M; Cappellano, G; Carlsson, M; Demetz, E; Dietrich, H; Foti, M; Hackl, H; Jakic, B; Onestingel, E; Ploner, C; Wick, C; Wick, G, 2019) |
| "Atherosclerosis is closely related to vascular dysfunction and hypertension." | ( Ahn, YM; Eun, SY; Han, BH; Hong, MH; Kang, DG; Kim, HY; Lee, HS; Lee, JG; Lee, YJ; Seo, CS; Shin, HK; Yoon, JJ, 2018) |
| "Atherosclerosis is a major underlying cause of ischemic heart diseases, ischemic stroke, and peripheral artery disease." | ( Francuz, T; Gallego-Colon, E; Wojakowski, W, 2018) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Chen, M; Chen, X; Li, S; Sun, Y; Wang, C; Xiao, Z; Xie, X; Yang, M; Zhong, L, 2018) |
| "Atherosclerosis is a common age-related disorder and is the major cause of morbidity and mortality in the developed countries." | ( Al-Zaghal, A; Alavi, A; Constantinescu, CM; Høilund-Carlsen, PF; Moghbel, M; Werner, TJ, 2018) |
| "Atherosclerosis is believed to be the major cause of CVD, characterized by atherosclerotic lesion formation and plaque disruption." | ( Li, M; Ma, S; Wang, S; Zhang, Y; Zhu, P, 2018) |
| "Atherosclerosis is the predominant underlying pathology of many types of cardiovascular disease and is one of the leading causes of death worldwide." | ( Benne, N; Jiskoot, W; Kuiper, J; Leboux, RJT; Lozano Vigario, F; Slütter, B; van Duijn, J; van Veelen, P, 2018) |
| "Atherosclerosis is a chronical inflammatory disease in arterial walls, which is involved in oxidative stress and endothelial dysfunction." | ( Guo, C; Jing, Y; Li, P; Li, QZ; Liu, Z; Lu, JX; Niu, HF; Ou, WS; Song, P; Xu, J; Yin, YL; Zhu, ML, 2019) |
| "Atherosclerosis is a chronic inflammatory process." | ( Li, Q; Li, Y; Tan, Y; Yi, G; Zeng, Y; Zheng, Z; Zhu, X, 2019) |
| "Atherosclerosis is a major risk factor for cardiovascular disease (CVD) and is known to be an inflammatory process." | ( Chrøis, KM; Dela, F; Dohlmann, TL; Hansen, M; Helge, JW; Kelly, B; Kuhlman, ACB; Larsen, S; Morville, T; Sahl, RE, 2019) |
| "Atherosclerosis is a chronic inflammatory disease which may lead to major cardiovascular events." | ( Aini, FN; Bekti, RS; Heriansyah, T; Nafisatuzzamrudah, N; Primardhika, RF; Ridwan, M; Wihastuti, TA; Wijayanti, M, 2018) |
| "Atherosclerosis is recognized as a chronic inflammatory condition that begins with the dysfunction or activation of arterial endothelium." | ( Igarashi, T; Iketani, M; Kawaguchi, H; Komatsu, M; Ohsawa, I; Ohtani-Kaneko, R; Sakane, I; Sekimoto, K; Takahashi, H; Takahashi, M, 2018) |
| "Atherosclerosis is characterized as a chronic inflammatory disease and macrophage-derived foam cells play a central role during the pathologic processes." | ( Bai, J; Deng, L; Fan, J; Liu, Q; Nong, J; Peng, L; Wang, G; Wang, Y; Zhang, M; Zhang, T; Zhao, Y, 2018) |
| "Atherosclerosis is a widespread and complicated disease involving phenotypic modulation and transdifferentiation of vascular smooth muscle cells (SMCs), the predominant cells in aorta, as well as changes in endothelial cells and infiltrating monocytes." | ( Baribault, C; Ehrlich, KC; Ehrlich, M; Lacey, M, 2019) |
| "Atherosclerosis is a major contributor to cardiovascular disease, with a higher burden on men than women during the occupational age." | ( Agodi, A; Barchitta, M; Bauerova, H; Hruskova, J; Jakubik, J; Kunzova, S; Maugeri, A; Medina-Inojosa, JR; Sochor, O; Vinciguerra, M, 2019) |
| "Atherosclerosis is characterized by chronic low-grade inflammation with concomitant lipid accumulation in the arterial wall." | ( Batthyány, C; Dapueto, R; Escande, C; Galliussi, G; Kamaid, A; López, GV; Malacrida, L; Rodriguez-Duarte, J; Rossello, J; Schopfer, FJ, 2019) |
| "Multisite atherosclerosis is greater with MetS or DM, and predicts CVD and CHD events." | ( Allison, MA; Bertoni, AG; Budoff, MJ; Criqui, MH; Evans, MA; Malik, S; Ouyang, P; Polak, JF; Wong, ND; Zhao, Y, 2019) |
| "Atherosclerosis is a chronic arterial disease characterized by vascular inflammation, accumulation of lipids in the arterial wall, and formation and growth of atherosclerotic plaques followed by ischemia." | ( Chistiakov, DA; Grechko, AV; Orekhov, AN; Romanenko, EB; Zhang, D, 2020) |
| "Atherosclerosis is the pathological process in arteries due to the plaque formation that is responsible for several diseases like heart disease, stroke and peripheral arterial disease." | ( Chen, JR; Deng, J; Du, Z; Hao, E; Hou, X; Hsiao, CD; Lai, YH; Pang, G; Xie, J; Zhou, K, 2019) |
| "Atherosclerosis is a progressive, chronic inflammation in arterial walls." | ( Bai, HL; Dai, XY; Guo, FX; Hu, YW; Kang, CM; Li, P; Lu, JB; Lu, ZF; Wang, Q; Wu, Q; Xiao, L; Xu, BM; Xu, YJ; Ye, S; Zheng, L, 2019) |
| "Atherosclerosis is a major cardiovascular disease that causes ischemia of the heart, brain, or extremities, and can lead to infarction." | ( Chen, B; Chen, X; Cheng, D; Li, X; Lin, C; Sun, W; Wang, J; Wu, T; Xiao, H, 2019) |
| "Atherosclerosis is a progressive disease characterized by chronic inflammation of the arterial walls, associated with genetic and infectious factors." | ( Almeida, NCC; Ayin Fossa, MA; Brasil Costa, I; Ishak, MOG; Ishak, R; Lima, SS; Queiroz, MAF; Vallinoto, ACR, 2019) |
| "Biomarkers of atherosclerosis are required to monitor and prevent disease progression." | ( Fan, J; Johno, H; Kimura, T; Mori, Y; Niimi, M; Takeda, S; Tanigawa, T; Yamada, M; Yoshimura, K, 2018) |
| "Atherosclerosis is associated with the increased trans-sialidase activity, which can be detected in the blood plasma of atherosclerosis patients." | ( Glanz, VY; Grechko, AV; Myasoedova, VA; Orekhov, AN, 2019) |
| "Atherosclerosis is exacerbated by iron-triggered lipid profile alterations, vascular permeabilization, sustained endothelial activation, elevated pro-atherogenic inflammatory mediators, and reduced nitric oxide availability." | ( Altamura, S; Garbowski, M; Hentze, MW; Muckenthaler, MU; Passos, ST; Porto, G; Seide, SE; Silva, AMN; Simmelbauer, A; Spaich, S; Sparla, R; Vinchi, F, 2020) |
| "Atherosclerosis is a prevalent disease affecting a large portion of the population at one point in their lives." | ( Calcagno, C; Coolen, BF; Daal, MRR; Nederveen, AJ; Strijkers, GJ; Wüst, RCI, 2019) |
| "Atherosclerosis is still the major cause of morbidity and mortality all over the world." | ( Cai, X; Du, X; Fu, W; Hu, X; Ma, R; Zhang, C, 2019) |
| "Atherosclerosis is a complex inflammatory disease that involves disrupted cellular cholesterol levels and formation of foam cells." | ( Bai, HL; Ding, L; Guo, FX; Hu, YW; Kang, CM; Li, P; Lu, ZF; Tang, JY; Wang, Q; Wu, Q; Xiao, L; Xu, BM; Xu, YJ; Zheng, L, 2019) |
| "Atherosclerosis is the major underlying factor for most CVD." | ( Li, L; Li, Q; Shen, X; Tao, Y; Wang, X; Xu, W; Yin, H; Zhong, S, 2019) |
| "Atherosclerosis is a type of CVD related to hypertension, diabetes, high levels of cholesterol, smoking, oxidative stress, and age." | ( Avgerinos, NA; Neofytou, P, 2019) |
| "Introduction: Atherosclerosis is a trigger in the development of cardiovascular disease." | ( Baryshnik, AI; Karlova, OO; Kuzminska, OV, 2019) |
| "Atherosclerosis is the key factor responsible for cardiovascular events, which is a major cause of morbidities and mortalities worldwide." | ( Kim, JY; Shim, SH, 2019) |
| "Atherosclerosis is the main killer in the western world." | ( Arnebrant, T; Bengtsson, E; Cárdenas, M; Forsyth, VT; Fredrikson, GN; Haertlein, M; Lind, TK; Lund, R; Maric, S; Moulin, M; Pomorski, TG; Raida, MR; Rogers, S; Wenk, MR, 2019) |
| "Atherosclerosis is a chronic inflammatory disease triggered by endothelial dysfunction and exaggerated by macrophage infiltration." | ( Wang, X; Wang, YJ; Xu, L; Yang, XC; Zhang, J; Zhao, WS, 2019) |
| "Atherosclerosis is a condition with the vascular accumulation of lipid plaques, and its main major contributing factor is endothelial injury induced by oxidized low-density lipoprotein (ox-LDL)." | ( Li, J; Zhang, X; Zhu, Z, 2019) |
| "Atherosclerosis is a multifactorial life-threatening disease which an epidemiologic study in Northeastern Iran showed its association with HTLV-1 infection." | ( Azad, FJ; Farid Hosseini, R; Garivani, YA; Ghezeldasht, SA; Mohammadi, FS; Mosavat, A; Mozayani, F; Rezaee, SA; Shabestari, M, 2019) |
| "Atherosclerosis is the major cause of cardiovascular diseases, which are considered the fatal ailment globally." | ( Din, AU; Hassan, A; Li, T; Luo, Y; Wang, G; Wang, Y; Zhang, K; Zhu, Y, 2019) |
| "Atherosclerosis is a prevalent inflammatory condition and a frequent cause of morbidity and mortality worldwide." | ( Schulz, C; Stark, K; Stremmel, C, 2019) |
| "Atherosclerosis is associated with a compromised endothelial barrier, facilitating the accumulation of immune cells and macromolecules in atherosclerotic lesions." | ( Beckers, L; Beldman, TJ; de Winther, MPJ; Desclos, E; Grootemaat, AE; Hoebe, RA; Huveneers, S; Kluza, E; Krawczyk, PM; Lutgens, E; Malinova, TS; Misiak, ALS; Mulder, WJM; Neele, AE; Sluimer, JC; van der Velden, S; van der Wel, NN; van Roomen, CPAA; van Veen, HA, 2019) |
| "Atherosclerosis is the main cause of reduced life quality and expectancy in diabetics, whereas diabetic nephropathy and retinopathy are the most common causes of end-stage renal disease and blindness." | ( Fantauzzi, CB; Iacobini, C; Menini, S; Pugliese, G, 2020) |
| "Atherosclerosis is the primary etiological factor associated with acute coronary syndrome (ACS)." | ( Bulut, A; Demirtaş, AO, 2019) |
| "Atherosclerosis is a major cardiovascular disease and one of the commonest causes of mortality in the world." | ( Elbeltagy, MAF; Elkholy, WB; Salman, AS, 2019) |
| "Atherosclerosis is a chronic inflammatory disease which is a major cause of coronary heart disease and stroke in humans." | ( Malekmohammad, K; Rafieian-Kopaei, M; Sewell, RDE, 2019) |
| "Atherosclerosis is a common and deadly cardiovascular disease with extremely high prevalence." | ( Chen, T; Han, Y; Liu, Y; Song, S; Sun, Z, 2019) |
| "Atherosclerosis is a chronic inflammatory disease and a leading cause of coronary artery disease, peripheral vascular disease and stroke." | ( Navashenaq, JG; Reiner, Ž; Renani, PG; Sahebkar, A; Taghizadeh, E; Taheri, F, 2019) |
| "Atherosclerosis is a kind of chronic cardiovascular disease, characterized by oxidized low-density lipoprotein (ox-LDL) accumulation in macrophage." | ( Fan, L; Li, Q; Liu, Q; Wang, X; Yuan, L; Zhang, Z, 2020) |
| "Today atherosclerosis is considered as a main cause of death in the worldwide." | ( Afshari, R; Farkhondeh, T; Mehrpour, O; Samarghandian, S, 2020) |
| "Atherosclerosis is an inflammatory chronic disease affecting arterial vessels and leading to vascular diseases, such as stroke and myocardial infarction." | ( Della-Morte, D; Infante, M; Rundek, T; Sacco, RL; Simonetto, M, 2019) |
| "Atherosclerosis is a chronic disease characterized by the formation of calcified, arterial plaques." | ( Chin, DD; Chung, EJ; Magee, GA; Mel de Fontenay, M; Plotkin, A; Wang, J, 2019) |
| "Atherosclerosis is a progressive vascular disease triggered by interplay between abnormal shear stress and endothelial lipid retention." | ( Anderson, DG; Aryal, B; Canfran-Duque, A; Chen, PY; Chittenden, TW; Cilfone, NA; Dahlman, JE; Fernandez-Hernando, C; Gujja, S; Gulcher, J; Jiao, Y; Kauffman, KJ; Kusters, P; Li, G; Liu, R; Lutgens, E; Malagon-Lopez, J; Pober, JS; Qin, L; Schwartz, MA; Sehgal, A; Simons, M; Sun, H; Sun, L; Tellides, G; Wang, Z; Zhang, X, 2019) |
| "Atherosclerosis is a chronic inflammatory disease involving immunological and metabolic processes." | ( Agardh, H; Baumgartner, R; Berg, M; Bottcher, G; Forteza, MJ; Gisterå, A; Hansson, GK; Hurt-Camejo, E; Kareinen, I; Ketelhuth, DFJ; Polyzos, KA, 2020) |
| "Because atherosclerosis is a chronic inflammatory disease, possible mechanisms by which MTX and DOX reduce inflammation have been investigated." | ( Anderson, DR; Clemens, DL; Duryee, MJ; Hall, JH; Klassen, LW; Mikuls, TR; Thiele, GM; Zimmerman, MC, 2020) |
| "Atherosclerosis is a common cardiovascular disorder and is characterized by damage of endothelial cells, cell inflammation, hyper-proliferation of vascular smooth muscle cells and the accumulation of extracellular lipids and fibrous tissues." | ( Chen, Y; Chi, J; Guo, H; Ji, Z; Jiang, F; Lv, H; Ni, T; Peng, F; Ru, A; Sun, H; Zhang, J, 2020) |
| "Atherosclerosis is a common comorbidity of type II diabetes and a leading cause of death worldwide." | ( Chang, W; Mao, Z; Miao, P; Zhao, L; Zheng, H; Zhou, Z; Zhu, F, 2019) |
| "Atherosclerosis is the most common cause of cardiac deaths worldwide." | ( Álvarez-Córdoba, M; de la Mata, M; Munuera, M; Pastor-Maldonado, CJ; Povea-Cabello, S; Sánchez-Alcázar, JA; Suárez-Carrillo, A; Suárez-Rivero, JM; Talaverón-Rey, M; Villalón-García, I; Villanueva-Paz, M, 2019) |
| "Atherosclerosis is a major cause of mortalities and morbidities worldwide." | ( Din, AU; Gregersen, H; Hassan, A; Wang, G; Yin, T; Zhu, Y, 2019) |
| "Atherosclerosis is one of the leading causes of death in patients with cardiovascular diseases worldwide." | ( Jiang, JG; Wu, FC, 2019) |
| "Atherosclerosis is the major cause of ischemic coronary heart diseases and characterized by the infiltration of cholesterol-accumulating macrophages in the vascular wall." | ( Aoki, J; Ishimaru, K; Kano, K; Kurano, M; Okamoto, Y; Proia, RL; Saigusa, D; Takuwa, N; Takuwa, Y; Yatomi, Y; Yoshioka, K, 2019) |
| "Atherosclerosis is a major disease that seriously harms human health and is known as the "number one killer" in developed countries and the leading cause of death worldwide." | ( Chen, J; Wei, D; Wu, J; Wu, S; Xu, G; Zhang, S, 2020) |
| "Atherosclerosis is a main reason for peripheral vascular disease." | ( Cai, C; Li, C; Sun, J; Ye, L; Zheng, X, 2020) |
| "Atherosclerosis is a leading cause of cardiovascular disease worldwide, and hypercholesterolemia is a major risk factor." | ( de Haas, R; Frambach, SJCM; Rongen, GA; Russel, FGM; Schirris, TJJ; Smeitink, JAM, 2020) |
| "Atherosclerosis is a leading cause of death in developed countries." | ( Cheng, A; Cheng, J; Clifford, BL; de Aguiar Vallim, TQ; Hedin, U; Maegdefessel, L; Pamir, N; Sallam, T; Tarling, EJ; Wu, X, 2020) |
| "Atherosclerosis is the major cause of PAD." | ( Arslan, C; Bayoglu, B; Cengiz, M; Dirican, A; Junusbekov, Y, 2020) |
| "BACKGROUND Atherosclerosis is a chronic and multifactorial disease, and it is the main reason of coronary heart disease, cerebral infarction, and peripheral vascular disease, which leads to the formation of lesions in arterial blood vessels." | ( An, L; Jia, Z; Lu, Y; Teng, X; Wang, J; Wang, S; Xu, C, 2019) |
| "Atherosclerosis is a complex and long-lasting disorder characterized by chronic inflammation of arteries that leads to the initiation and progression of lipid-rich plaques, in which monocytes/macrophages play the central role in endothelial inflammation and taking up these lipids." | ( Abdollahi, E; Azhdari, S; Karimzadeh, MR; Mohammadian Haftcheshmeh, S; Momtazi-Borojeni, AA; Vahedi, P, 2020) |
| "Atherosclerosis is a chronic inflammation condition resulting from the interaction between lipoproteins, monocyte-derived macrophages, T lymphocytes, and other cellular elements in the arterial wall." | ( Chen, Y; Ding, XS; Feng, N; Feng, XF; Liu, F; Yang, LC; Yang, XJ; Zhu, SX, 2020) |
| "Atherosclerosis is a chronic inflammatory disease causing coronary heart attacks and strokes." | ( Chen, J; Gu, X; Su, C; Ullah, H; Wei, Y; Wu, X; Xiao, L; Xie, Q; Xiong, F; Zha, L; Zheng, Z, 2020) |
| "Atherosclerosis is one of the main causes of cardiovascular diseases." | ( Li, H; Li, Z; Liu, F; Shan, S, 2020) |
| "Atherosclerosis is the process that underlies heart attack and stroke." | ( Flores, AM; Hosseini-Nassab, N; Ingelsson, E; Jarr, KU; Koh, AL; Kojima, Y; Leeper, NJ; Lotfi, M; Nanda, V; Sinclair, R; Smith, BR; Tsantilas, P; Wang, Y; Weissman, IL; Wirka, R; Ye, J; Zeng, Y; Zhu, X, 2020) |
| "Atherosclerosis is an inflammatory disease characterized by lipid deposits in the subendothelial space leading to severe inflammation." | ( Chiang, CH; Lee, MF; Lin, SJ; Lin, WW; Liu, HC; Song, PP; Wu, TJ, 2020) |
| "Atherosclerosis is a serious cardiovascular disease, featuring inflammation, abnormal proliferation and migration of vascular smooth muscle cells (VSMCs)." | ( Chen, LD; Chen, YQ; Cheng, YY; Jing, DD; Li, ZH; Lin, CY; Liu, ZQ; Yan, PK; Yuan, ZW; Zhu, WT, 2020) |
| "Atherosclerosis is characterized as a chronic inflammatory response to cholesterol deposition in arteries." | ( Song, D; Wang, J; Wu, J; Yan, Y, 2020) |
| "Atherosclerosis is the primary cause of several cardiovascular diseases." | ( Liu, H; Liu, M; Lu, C; Suo, R; Zhao, H, 2020) |
| "Atherosclerosis is related to fat accumulation in the arterial walls and vascular stiffening, and results in acute coronary syndrome which is commonly associated with acute myocardial infarction." | ( Garofallo, SB; Lorenzon Dos Santos, J; Marcadenti, A; Quadros, AS; Weschenfelder, C, 2020) |
| "Atherosclerosis is one of the leading causes of human morbidity globally and reduced bioavailability of vascular nitric oxide (NO) has a critical role in the progression and development of the atherosclerotic disease." | ( Malekmohammad, K; Rafieian-Kopaei, M; Sewell, RDE, 2020) |
| "Arterial atherosclerosis is the main pathological cause of coronary artery disease and peripheral arterial disease." | ( Ito, F, 2021) |
| "Atherosclerosis is characterized by an inflammatory disease linked to excessive lipid accumulation in the artery wall." | ( Barton, RH; Burcelin, R; Dumas, ME; Federici, M; Fernández-Real, JM; Hoyles, L; Mayneris-Perxachs, J; Puig, J, 2020) |
| "Atherosclerosis is one of leading phenotypes of cardiovascular diseases, featured with increased vascular intima-media thickness (IMT) and unstable plaques." | ( Fang, Y; Wang, F; Wang, J; Wang, Y; Zhang, L, 2020) |
| "Atherosclerosis is a progressive vascular disease representing the primary cause of morbidity and mortality in developed countries." | ( Armani, A; Caprio, M; Cecconi, F; De Zio, D; Filippini, A; Giampietri, C; Mammi, C; Mandatori, S; Marzolla, V; Pacella, I; Padula, F; Piconese, S; Savoia, C; Starace, D; Taurino, M; Vitiello, L, 2020) |
| "Atherosclerosis is the leading cause of cardiovascular diseases (CVD) with high incidence rate and mortality rate." | ( Pan, C; Shen, D; Shi, H; Tang, X; Wang, X; Yin, R, 2020) |
| "Atherosclerosis is a chronic inflammatory disease affecting the aorta and is a major cause of cardiovascular disease." | ( Ha, SJ; Hong, YS; Kim, YE; Kim, YH; Lee, J; Lee, NH; Park, J; Song, KM, 2020) |
| "Atherosclerosis is a multifactorial disease that develops and progresses in the arterial wall in response to a variety of stimuli." | ( Du, L; Feng, Y; Guo, S; Mohan, SK; Veeraraghavan, VP; Wan, J, 2020) |
| "Atherosclerosis is associated with chronic inflammation and lipid metabolism." | ( Fu, G; Li, Y; Luan, Y; Lv, Q; Xu, T; Zhang, W; Zhao, L, 2020) |
| "Atherosclerosis is a multifactorial chronic disease, initiated by an endothelial dysfunction." | ( Autran, LJ; Brazão, SC; Brito, FCF; Lima, GF; Lopes, RO; Mendes, ABA; Motta, NAV, 2020) |
| "Atherosclerosis is an inflammatory disease resulting from subendothelial accumulation of lipoprotein-derived cholesterol in susceptible arterial segments, ultimately leading to the formation of clinically significant atherosclerotic plaques." | ( Jamialahmadi, T; Kovanen, PT; Mahjoubin-Tehran, M; Sahebkar, A; Xu, S, 2020) |
| "Atherosclerosis is a disease caused by multiple factors, it mainly occurs on the walls of large and medium blood vessels and atherosclerotic plaques form in the intima of the blood vessels." | ( Cui, X; Miao, J; Zang, X; Zhang, J, 2020) |
| "Atherosclerosis is a chronic inflammatory disease that is characterized by the formation of lipid rich plaques in the wall of medium to large sized arteries." | ( Grover, SP; Mackman, N, 2020) |
| "Atherosclerosis is the common vascular disease." | ( Chen, X; Sun, T; Yan, J; Yan, R; Yu, Y, 2020) |
| "Atherosclerosis is a chronic disease characterized by lipid retention and inflammation in the artery wall." | ( Sahebkar, A; Tian, K; Xu, S; Xu, Y, 2020) |
| "Atherosclerosis is a multifactorial vascular disease that develops in the course of a lifetime." | ( Olie, RH; Spronk, HMH; Ten Cate, H; van der Meijden, PEJ, 2022) |
| "Atherosclerosis is a chronic disease characterized by lipid accumulation and chronic inflammation of the arterial wall, which is the pathological basis for coronary heart disease, cerebrovascular disease and thromboembolic disease." | ( Cao, Q; Ji, A; Liang, H; Song, S; Xiao, H; Xing, M; Zhang, Q; Zhao, J, 2020) |
| "Atherosclerosis is a common reason for acute cardio-cerebral vascular diseases." | ( Cui, L; Ding, Z; Quan, X; Sun, J; Xie, Z; Zhang, L; Zhao, J, 2020) |
| "Atherosclerosis is characterized by endothelial cell dysfunction followed by lesion formation, arterial stenosis, potentially arterial occlusion, and severe outcomes." | ( Ding, Z; Quan, X; Xie, Z; Zhang, L; Zhao, J, 2020) |
| "Atherosclerosis is regarded as the disease of the arterial vasculature." | ( Jayachandran, M; Qu, S, 2021) |
| "Atherosclerosis is the condition of narrowing of arteries due to plaque buildup on the artery walls." | ( Chen, L; Wang, C; Wu, Y, 2020) |
| "Atherosclerosis is a chronic disease of arteries, which constitutes the pathological basis of a series of cardiovascular diseases." | ( Fan, LJ; Li, M; Liu, J; Tan, TT; Zhang, H; Zhou, YL; Zhu, JQ, 2022) |
| "Atherosclerosis is a chronic cardiovascular disease and contributes to pathogenesis of most myocardial infarction and ischemic stroke." | ( Gong, X; Hao, Y; Xiong, R, 2021) |
| "Atherosclerosis is a complex disease, influenced by both genetic and non-genetic factors." | ( Hou, H; Zhao, H, 2021) |
| "Atherosclerosis is caused by a monocyte-mediated inflammatory process that, in turn, is stimulated by cytokines and adhesion molecules." | ( Aita, CAM; Cunha, EBB; Herai, RH; Lima, J; Serrato, JA; Silva, NFD, 2020) |
| "Alimentary atherosclerosis is associated with a significant decrease in the content of phosphatidylcholine, the phospholipid that provides antioxidant protection, in the plasma membrane of liver cells, while the level of phosphatidic acid that initiates generation of superoxides, on the contrary, increases." | ( Bezrukov, DA; Kaplun, AP; Leskova, GF; Lvovsky, AI, 2020) |
| "Atherosclerosis is a chronic vascular disease and characterized by accumulation within the intima of inflammatory cells, smooth muscle cells, lipid, and connective tissue." | ( Ahn, YM; Han, BH; Hong, MH; Kang, DG; Kim, HY; Lee, HS; Lee, YJ; Son, CO; Yoon, JJ, 2021) |
| "Atherosclerosis is regarded as chronic inflammatory disease." | ( Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Wang, M; Wang, Y; Yan, D; Zhang, C; Zhao, C, 2021) |
| "Atherosclerosis is a non-resolving inflammatory condition that underlies major cardiovascular diseases." | ( Alves Castro, I; Araki, K; de Castro Leão, M; de Cristo Soares Alves, A; Helena Poliselli Farsky, S; Klimuk Uchiyama, M; Raffin Pohlmann, A; Sandri, S; Stanisçuaski Guterres, S, 2021) |
| "Atherosclerosis is a chronic inflammatory, metabolic, and epigenetic disease, which leads to the life-threatening coronary artery disease." | ( Chen, W; Feng, X; Li, L; Xu, S; Zhang, L; Zhang, S, 2021) |
| "Atherosclerosis is an important medical problem of modern society." | ( Chook, P; Feng, XH; Koon, KV; Kwok, TCY; Lee, APW; Leong, HC; Woo, KS; Yip, TWC, 2021) |
| "Atherosclerosis is a common cause of CVD that involves inflammation and the accumulation of cholesterol-laden cells in the arterial wall." | ( Citrin, KM; Fernández-Hernando, C; Suárez, Y, 2021) |
| "Atherosclerosis is the dominant pathologic basis of many cardiovascular diseases." | ( Chang, L; Chen, YE; Garcia-Barrio, MT; Guo, Y; Hu, W; Liang, W; Lu, H; Luo, Y; Schwendeman, A; Wang, H; Zhang, J, 2022) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall." | ( Kim, CW; Oh, ET; Park, HJ, 2021) |
| "Atherosclerosis is a chronic vascular disease posing a great threat to public health." | ( Guo, X; He, L; Liu, H; Lu, L; Lv, C; Qin, Y; Ruan, W; Wan, X; Zhang, X, 2021) |
| "Atherosclerosis is characterized by the plaque formation that restricts intraarterial blood flow." | ( Cheng, HM; Chien, CS; Chien, S; Chien, Y; Chiou, SH; Huo, TI; Juan, CC; Li, JY; Nguyen, P; Tsai, PH; Wang, ML; Yarmishyn, AA, 2021) |
| "Atherosclerosis is not only a lipid metabolism disorder, but is also a chronic inflammatory one." | ( Abdallah, R; Ali, AH; Ayoub, MA; Dakroub, A; Eid, AH; El-Yazbi, AF; Iratni, R; Orekhov, A; Shaer, F; Yassine, HM; Younis, N; Zibara, K, 2021) |
| "Atherosclerosis is a chronic vascular inflammatory disease, and is associated with oxidative stress and endothelial dysfunction." | ( Huang, J; Ji, C; Yi, H; Zhang, W; Zheng, M, 2021) |
| "Atherosclerosis is a disease with both morphological and functional damage, and vascular endothelial function is damaged in the early stage with corresponding pathological changes." | ( Deng, S; Jiang, Q; Lu, X; Zhang, Y, 2021) |
| "Atherosclerosis is the leading cause of death in developed countries." | ( Breunig, M; Goepferich, A; Groner, J, 2021) |
| "Atherosclerosis is a major cause of human cardiovascular disease, which is the leading cause of mortality around the world." | ( Banach, M; Jamialahmadi, T; Javadifar, A; Johnston, TP; Rastgoo, S; Sahebkar, A, 2021) |
| "Atherosclerosis is a chronic lipid-induced inflammation of the vessel wall." | ( Chen, D; Jiang, M; Wang, G; Wang, K; Zheng, Y, 2021) |
| "Atherosclerosis is a chronic lipid disfunction and inflammatory disease, which is characterized with enriched foam cells and necrotic core underneath the vascular endothelium." | ( Dong, Z; Feng, K; Hua, Y; Ma, C; Wu, H; Yang, S; Zhang, C; Zhang, H; Zhang, J; Zhu, Y, 2021) |
| "Atherosclerosis is the underlying pathogenesis of cardiovascular events caused by inflammation, and dietary intervention has been recommended as one fundamental prevention strategy." | ( Chen, H; He, H; Jiang, C; Li, H; Liu, J; Mei, G; Tang, Y; Xiao, L; Yao, P; Yu, J; Zeng, H, 2021) |
| "Atherosclerosis is a chronic inflammatory disease that can cause acute cardiovascular events." | ( Chen, GQ; Chen, J; Cui, ZJ; Li, Y; Li, ZH; Wang, W; Wu, FQ; Zhang, SJ; Zhang, YD, 2021) |
| "Atherosclerosis is a persistent inflammatory disorder specified by the dysfunction of the arteries, the world's leading cause of cardiovascular diseases." | ( Ahmed, EA; Alzahrani, AM; Rajendran, P; Veeraraghavan, VP, 2021) |
| "Atherosclerosis is a chronic inflammatory disease associated with macrophage aggregate and transformation into foam cells." | ( Abe, Y; Adachi, J; Hirata, SI; Hosomi, K; Isoyama, J; Kunisawa, J; Morimoto, S; Nagatake, T; Node, E; Saika, A; Sawane, K; Shibata, Y; Tomonaga, T, 2021) |
| "Atherosclerosis is a macrophage-related inflammatory disease that remains a leading cause of death worldwide." | ( Aonuma, K; Kosuge, H; Kuroiwa, K; Nakamura, M; Oyane, A; Shimizu, Y, 2021) |
| "Atherosclerosis is responsible for high morbidity and mortality rates around the world." | ( Assis, LHP; Dorighello, GG; Oliveira, HCF; Paim, BA; Rentz, T; Rovani, JC; Vercesi, AE, 2022) |
| "Accelerated atherosclerosis is a well-established phenomenon after coronary artery bypass grafting surgery (CABG)." | ( Abazid, RM; Akincioglu, C; Bureau, Y; Kiaii, B; Romsa, JG; Vezina, WC; Warrington, JC, 2021) |
| "Atherosclerosis is the main underlying mechanism of myocardial infarction." | ( Andersson, EM; Angerås, O; Barregard, L; Bergström, G; Borné, Y; Engström, G; Fagerberg, B; Fagman, E; Forsgard, N; Harari, F; Hjelmgren, O; Lundh, T; Persson, M; Sallsten, G, 2021) |
| "Atherosclerosis is a multifactorial disease, for which the etiology is so complex that we are currently unable to prevent it and effectively lower the statistics on mortality from cardiovascular diseases." | ( Kuzan, A; Wiglusz, RJ; Wujczyk, M, 2021) |
| "Atherosclerosis is a multifactorial disease triggered and sustained by risk factors such as high cholesterol, high blood pressure and unhealthy lifestyle." | ( Cao, Y; Darwitan, A; Das, P; Muktabar, A; Ng, KW; Nguyen, LTH; Rakshit, M; Tang, J; Venkatraman, S; Vizetto-Duarte, C; Wong, YS, 2021) |
| "Atherosclerosis is a chronic inflammatory disease of the small and medium arteries wall caused by maladaptive local immune responses, which underpins several cardiovascular diseases (CVD)." | ( Gluvic, Z; Isenovic, ER; Obradovic, M; Sudar-Milovanovic, E; Zaric, B, 2022) |
| "Atherosclerosis is a well-known risk factor of cardiovascular disease development." | ( Avagimyan, A, 2022) |
| "The development of atherosclerosis is closely associated with disorder of lipid metabolism." | ( Liu, Y; Lu, B; Wang, M; Xiao, F; Yang, X; Zhao, T, 2021) |
| "Atherosclerosis is the underlying contributing factor of cardiovascular disease, which is a process of inflammation and lipid-rich lesion." | ( Li, L; Liu, L; Lu, J; Tan, L, 2021) |
| "Atherosclerosis is a pro-oxidative and pro-inflammatory disease state, which is the underlying cause of most cardiovascular events, estimated to affect 5." | ( Collins, BJ; Delaney, CL; Miller, MD; Mukherjee, MS, 2021) |
| "Atherosclerosis is a widespread and progressive chronic arterial disease that remains the leading cause of mortality and morbidity worldwide." | ( Abu-Yousef, IA; Majdalawieh, AF; Yousef, SM, 2021) |
| "Atherosclerosis is a chronic vascular inflammatory disease with complex pathogenesis." | ( Deng, Y; Li, Y; Liao, L; Peng, C; Wang, C; Wang, J; Xue, X; Zhou, M, 2021) |
| "The pathogenesis of atherosclerosis is closely related to endothelial cell injury caused by lipid peroxidation-induced ferroptosis." | ( He, L; Huang, XZ; Li, C; Li, ZZ; Liu, YY; Wang, K; Xiong, Y; Zhang, W, 2021) |
| "Atherosclerosis is characterized by focal accumulations of lipid within the arterial wall, thought to arise from effects of hemodynamic wall shear stress (WSS) on endothelial permeability." | ( Warboys, CM; Weinberg, PD, 2021) |
| "Atherosclerosis is a serious age-related disease, which has a tremendous impact on health care globally." | ( Ding, N; Hao, Y; Jiang, Y; Ma, F; Ma, S; Xiong, J; Xu, L; Yang, A; Zhang, H, 2021) |
| "Atherosclerosis is a disease of chronic inflammation." | ( English, CJ; Lohning, AE; Mayr, HL; Reidlinger, DP, 2022) |
| "Atherosclerosis is one of the underlying causes of cardiovascular disease." | ( Fan, G; Feng, K; Hua, Y; Kang, L; Ma, C; Wu, H; Xiang, J; Yang, G; Yang, S; Zhang, J, 2022) |
| "Atherosclerosis is a chronic inflammatory vascular disease, and inflammation plays a critical role in its formation and progression." | ( Ding, N; Dong, X; Gu, L; Jiang, Y; Liu, D; Wang, Y; Xu, L; Yang, A; Zhang, H, 2022) |
| "Atherosclerosis is a chronic inflammatory disease that may lead to the development of serious cardiovascular diseases." | ( Ishida, M; Kokubo, H; Miki, S; Suzuki, JI; Takashima, M; Yoshizumi, M, 2021) |
| "Atherosclerosis is an inflammatory disease of high lethality associated with endothelial dysfunction." | ( Chen, H; Chen, Y; Cui, H; Li, X; Lin, Y; Liu, X; Meng, Z; Shi, Y; Tang, X; Wang, Z; Xu, H; Yang, B; Zhang, Y; Zhao, H; Zhao, L; Zhu, M, 2022) |
| "Atherosclerosis is a complex phenomenon manifesting several features typical of chronic inflammation and disorders of lipid metabolism." | ( Blaha, MJ; Blumenthal, RS; Budoff, MJ; Burke, GL; Jorgensen, NW; Lloyd-Jones, D; Nasir, K; Wong, ND; Zeb, I, 2021) |
| "Atherosclerosis is an important pathological basis for cardiovascular disease." | ( Du, J; Li, S; Li, Y; Liu, S; Shen, M; Wang, J; Wu, X; Yang, Q; Yao, S; Zheng, X, 2021) |
| "Atherosclerosis is a cardiovascular disease that affects a majority of people around the world at old age." | ( Chen, XH; Deng, Y; Lu, L; Tan, Y; Yu, S, 2022) |
| "The occurrence of atherosclerosis is closely related to inflammation and lipid metabolism disorder." | ( Feng, H; Jin, M; Qin, H; Wang, Q; Wei, Y; Yan, S; Zhang, D; Zhao, L; Zheng, L, 2022) |
| "Atherosclerosis is a lipid-driven chronic inflammatory disease that leads to the formation of plaques in the inner lining of arteries." | ( Bony, BA; Chatzizisis, YS; Curtis, ET; Gee, CC; Kievit, FM; McCue, IS; Miller, HA; Pedrigi, RM; Ripperda, TJ; Schake, MA, 2021) |
| "Atherosclerosis is a disease that covers the arteries of the middle to large arteries and can affect the aorta to the coronary arteries." | ( Haiyun, Z; Lixia, G; Xia, Z, 2021) |
| "Atherosclerosis is a chronic inflammatory disease caused mainly by lipid accumulation and excessive inflammatory immune response." | ( Hao, Y; Liu, J; Wang, J; Wen, G; Yao, L, 2022) |
| "Atherosclerosis is a global disease with an extremely high morbidity and fatality rate, so it is necessary to develop effective treatments to reduce its impact." | ( Hao, Y; Li, Y; Liu, S; Shen, M; Wu, X; Yang, Q; Yao, Y; Zhao, Y, 2022) |
| "Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome." | ( Doulamis, IP; Iliopoulos, DC; Kaminiotis, VV; Kapelouzou, A; Kontogiannis, C; Mastrogeorgiou, M; Mylonas, KS; Nikiteas, N; Siasos, G; Spartalis, E; Spartalis, M; Toutouzas, K, 2021) |
| "Atherosclerosis is a chronic inflammatory disease implicated in oxidative stress and endothelial dysfunction." | ( Du, F; Huang, R; Jia, J; Li, J; Shen, X; Wang, Y; Yang, Q, 2022) |
| "Atherosclerosis is common in AF and poses additional risk to patients." | ( Abolbashari, M, 2022) |
| "Atherosclerosis is an inflammatory disease of the artery walls and involves immune cells such as macrophages." | ( Ali, AJ; Braumann, S; Denn, A; Durant, CP; Eckmann, L; Fan, Z; Ghosheh, Y; Hazen, SL; Jung, Y; Kiosses, WB; Kobiyama, K; Latz, E; Ley, K; Li, L; Mader, N; Makings, J; Mangan, M; Matsunami, H; McArdle, S; Mikulski, Z; Miyamoto, Y; Orecchioni, M; Owens, M; Roy, P; Vallejo, J; Wang, Z; Wen, L; Winkels, H, 2022) |
| "Atherosclerosis is widely accepted as an inflammatory disease." | ( Abdollahi, E; Delbandi, AA; Falak, R; Hajimiresmaiel, SJ; Keyhanfar, F; Shafiei, M, 2022) |
| "Atherosclerosis is driven by an inflammatory process of the vascular wall." | ( Freundt, GV; Frey, N; Hippe, HJ; Luedde, M; Nitz, JT; Preusch, M; von Samson-Himmelstjerna, FA; Waltenberger, J; Wieland, T, 2022) |
| "Atherosclerosis is considered the major cause of cardiovascular and cerebrovascular diseases, which are the leading causes of death worldwide." | ( Kawano, Y; Miyazaki, H; Miyazaki, K; Saiki, P; Yoshihara, M, 2022) |
| "Prevention of atherosclerosis is important because it is a risk factor for cardiovascular diseases globally." | ( Matsuo, M, 2022) |
| "Atherosclerosis is the most frequent cause of coronary artery disease (CAD) and inflammation is a key driver of its pathogenesis." | ( Agnello, F; Capodanno, D, 2022) |
| "Atherosclerosis is characterized by an accumulation of foam cells within the arterial wall, resulting from excess cholesterol uptake and buildup of cytosolic lipid droplets (LDs)." | ( Boucher, DM; Doyoung Kim, A; Emerton, C; Fairman, G; Geoffrion, M; Gharibeh, L; Mak, E; Nguyen, MA; Ouimet, M; Pietrangelo, A; Rasheed, A; Rayner, KJ; Robichaud, S; Vijithakumar, V; Wirka, R, 2022) |
| "Atherosclerosis is a major global health concern." | ( Hakkola, J; Hukkanen, J; Karpale, M, 2022) |
| "Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death." | ( Kalmykov, V; Kashirskikh, DA; Omelchenko, AV; Orekhov, AN; Poznyak, AV; Sukhorukov, VN, 2022) |
| "Atherosclerosis is a chronic inflammatory condition in which macrophages play a major role." | ( Alchami, E; Cummins, CL; Cybulsky, M; Desai, H; Dotan, I; Farber, G; Genest, J; Gronda, M; Gupta, V; Ikeda, J; Jongstra-Bilen, J; Karim, S; Le, H; Lewis, GF; Li, YZ; Minden, MD; Pollock-Tahiri, E; Rapps, J; Rehal, S; Robbins, C; Roth, Z; Saikali, MF; Schimmer, AD; Sivasubramaniyam, T; Tirosh, A; Wagner, KU; Woo, M; Xiao, C; Yang, J, 2022) |
| "Atherosclerosis is a chronic vascular inflammatory disease associated to oxidative stress and endothelial dysfunction." | ( Belce, A; Dumlu, FS; Guler, EM; Ozkan, BN; Sisman, BH, 2022) |
| "Atherosclerosis is a chronic inflammatory disease characterized by the formation of lipid-rich, fibrous plaques within the arterial wall of medium and large arteries." | ( Alahmadi, A; Alotibi, R; Chan, YH; Ramji, DP, 2022) |
| "Although atherosclerosis is still regarded as an incurable disease, at least in its more advanced stages, the discovery of endothelial progenitor cells (EPCs), with their ability to replace old and injured cells and differentiate into healthy and functional mature endothelial cells, has shifted our view of atherosclerosis as an incurable disease, and merged traditional theories of atherosclerosis pathogenesis with evolving concepts of vascular biology." | ( Altabas, V; Biloš, LSK, 2022) |
| "Atherosclerosis is primarily caused by the dysfunction of vascular endothelial cells and the subendothelial accumulation of oxidized forms of low-density lipoprotein (LDL)." | ( Andraos, R; Daher, J; El-Hajjar, L; El-Sabban, M; Hindieh, J, 2022) |
| "Atherosclerosis is a complex disease altering vasculature morphology, and subsequently flow, with progressive plaque formation, mural disruption, and lumen occlusion." | ( Edelman, ER; Marlevi, D; Nezami, FR; Niu, Y; Olender, ML, 2022) |
| "The pathogenesis of atherosclerosis is multifactorial, mainly driven by complex inflammatory processes." | ( Cuciuc, V; George, J; Haberman, D; Sella, G; Tuvali, O, 2022) |
| "Carotid atherosclerosis is increased 3 fold in people with DM." | ( Ns, R; St, K, 2022) |
| "Both EndMT and atherosclerosis are promoted by disturbed flow, whereas unidirectional laminar flow limits EndMT and is atheroprotective." | ( Günther, S; Jin, YJ; Liang, G; Offermanns, S; Shao, J; Wang, L; Wang, S; Xu, L; Yan, Y, 2022) |
| "Atherosclerosis is the most common arterial disease and is closely related to vascular calcification." | ( Chen, H; Li, ZZ; Liu, SH; Qi, YF; Wu, HF; Xiao, ZX; Zeng, ZF; Zhang, WB, 2022) |
| "Atherosclerosis is a chronic inflammatory disease that leads to tissue ischemia." | ( Gao, X; Qi, S; Tang, Y; Wang, Y; Wu, H; Zhang, T; Zhang, Z, 2022) |
| "Atherosclerosis is the main cause of cardiac and peripheral vessel infarction in developed countries." | ( Chiu, CC; Chuang, HL; Hsu, CC; Huang, YT; Hung, SW; Liu, JY; Lo, C; Sung, HH; Tsai, SC; Wang, CL, 2022) |
| "Atherosclerosis is associated with a haemostatic imbalance characterized by excessive activation of pro-inflammatory and pro-coagulant pathways." | ( Broncel, M; Gorzelak-Pabiś, P; Pawlos, A; Wojdan, K; Woźniak, E, 2022) |
| "Atherosclerosis is a primary cause of cardiovascular diseases and is caused by buildup of plaque and narrowing of blood vessels." | ( Brown, J; Cicalo, C; Crowley, LN; Han, BK; Kim, JK; Kim, YJ; Le, BL; Lee, JH; Lennon, SL; Li, Y; Pan, JH, 2022) |
| "Atherosclerosis is one of the potential causes of death in patients with cardiovascular disease." | ( Jiang, JG; Qin, SW; Wang, QH, 2022) |
| "Atherosclerosis is a chronic inflammatory disease of the arteries characterized by the accumulation of inflammatory cells in the arterial wall." | ( Azizi, M; Babaahmadi-Rezaei, H; Beheshti-Nasab, H; Ghaderi-Zefrehi, H; Mehta, JL; Rezaei, M, 2022) |
| "Atherosclerosis is an inflammatory disease with a high level of cholesterol in the blood." | ( Sui, D; Yu, H, 2022) |
| "Atherosclerosis is a major cause of mortality and morbidity worldwide." | ( Bobik, A; Bongcaron, V; Hulett, MD; Jirwanka, Y; Maluenda, A; Mehta, S; Nguyen, TK; Palasubramaniam, J; Peter, K; Srivastava, R; Walsh, APG; Wang, X, 2022) |
| "Atherosclerosis is a disease in which plaque builds up inside arteries." | ( Abdel-Reheim, ES; Ali, TM; Elesawy, BH; Ismail, BS; Mahmoud, B; Soliman, HA; Zaky, MY, 2022) |
| "Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity." | ( Baptista, D; Brandt, KJ; Burger, F; Miteva, K; Roth, A, 2022) |
| "Atherosclerosis is a chronic inflammatory disease of the artery wall associated with lipid metabolism imbalance and maladaptive immune response, which mediates most cardiovascular events." | ( Wang, D; Wang, X, 2022) |
| "Atherosclerosis is the primary cause of many cardiovascular diseases, and an increasing number of studies have shown that berberine could delay plaque formation and development." | ( Guo, Q; Jia, D; Liu, M; Shi, L; Wu, A; Yang, R; Yu, H; Zhang, D; Zhang, X; Zhao, M, 2022) |
| "Atherosclerosis is a major risk factor for myocardial infarction and ischemic stroke, which are the leading cause of death worldwide." | ( Chen, J; Deng, Q, 2022) |
| "Atherosclerosis is the main risk factor for cardiovascular disorders and represents a complex phenomenon associated with endothelial dysfunction and inflammation." | ( Alaylioglu, M; Dogan, AS; Dursun, E; Gezen-Ak, D; Onal, B; Ugurlucan, M; Yenmis, G, 2022) |
| "Diabetic atherosclerosis is characterized by hyperglycemia, hyperinsulinemia, and dyslipidemia." | ( Hu, C; Ma, C; Man, B; Xiang, J; Yang, G; Yang, S, 2022) |
| "Since atherosclerosis is considered to be a disease of aging, the composition of the supplement includes such essential minerals as magnesium and potassium, which are commonly used to prevent atherosclerosis, as well as vitamins C, E and the B-group vitamins in order to address the needs of the elderly." | ( Karanina, EV; Lapina, V; Pleshkova, N; Poznyakovsky, VM; Sorokopudov, VN; Takaeva, MA; Tokhiriyon, B; Vekovtsev, A, 2022) |
| "Atherosclerosis is the main cause of CVD in the general population, and in SLE, increased atherosclerosis, especially the prevalence of atherosclerotic plaques, has been demonstrated." | ( Frostegård, J, 2023) |
| "Atherosclerosis is one of the most important medical and social problems of modern society." | ( Kotlyarov, S, 2022) |
| "Atherosclerosis is the leading cause of cardiovascular disease worldwide, including in China." | ( Bots, ML; Chen, Y; Fu, L; Hu, B; Hu, H; Karlson, BW; Li, H; Li, X; Li, Z; Meng, X; Nie, Z; Wang, Y; Wei, D; Zhao, B; Zheng, H, 2022) |
| "Atherosclerosis is the main underlying pathology for many cardiovascular diseases (CVDs), which are the leading cause of death globally and represent a serious health crisis." | ( Hetherington, I; Totary-Jain, H, 2022) |
| "Atherosclerosis is a complex pathological process involving macrophages, endothelial cells and vascular smooth muscle cells that can lead to ischemic heart disease; however, the mechanisms underlying cell-to-cell communication in atherosclerosis are poorly understood." | ( Chen, J; Du, F; Li, K; Liu, P; Su, G; Wang, G; Wang, L; Wang, S; Wu, H; Yang, Y; Zhao, M, 2022) |
| "Atherosclerosis is a common cause of cardiovascular disease, which, in turn, is often fatal." | ( Litvinova, L; Moschetta, D; Orekhov, AN; Poggio, P; Poznyak, AV; Sukhorukov, VN, 2022) |
| "Atherosclerosis is the key pathogenesis of cardiovascular diseases; oxidative stress, which is induced by the generated excess reactive oxygen species (ROS), has been a crucial mechanism underlying this pathology." | ( Bi, X; Han, W; He, T; Huang, Y; Li, Y; Liu, M; Liu, Y; Ma, X; Wang, S; Wang, Y; Xiong, J; Yang, K; Zhang, B; Zhang, H; Zhang, Y; Zhao, J; Zhu, Y, 2022) |
| "Atherosclerosis is a disease in which lipids and inflammatory factors accumulate on the walls of arteries, forming plaques that eventually block the flow of blood." | ( Wang, D; Yuan, L; Zhou, Z, 2022) |
| "Atherosclerosis is a progressive cardiovascular disease in which cholesterol-rich plaques build up within arteries, increasing the risk of thrombosis, myocardial infarction, and stroke." | ( Ortega-Rivera, OA; Shin, MD; Steinmetz, NF, 2022) |
| "Development of atherosclerosis is initiated by the endothelial cell dysfunction along with inflammation and insulin resistance." | ( Babalic, FCA; Banciu, CD; Borza, C; Caraba, AE; Chelu, SC; Gurban, CV; Ilie Rosca, C; Kundnani, NR; Marius, P; Mederle, OA; Popa, MD; Sharma, A, 2022) |
| "Atherosclerosis is a chronic inflammatory disease of the arteries that can lead to thrombosis, infarction, and stroke and is the leading cause of mortality worldwide." | ( Busse, CE; Cobos-Figueroa, L; Del Monte-Monge, A; Delgado, P; Escolà-Gil, JC; Lorenzo, C; Martín-Ventura, JL; Martos-Folgado, I; Mur, SM; Ramiro, AR; Wardemann, H, 2022) |
| "Atherosclerosis is characterized by plaque formation in the arteries, resulting in vascular events such as ischemic stroke or myocardial infarction." | ( Kuebler, WM; Peters, L; Simmons, S, 2022) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall resulting in the formation of lipid-rich, fibrotic plaques under the subendothelium and is a key contributor to the development of CVD." | ( Baxter, AA; Chan, E; Hulett, MD; Nguyen, TK; Paone, S; Poon, IKH; Thomas, SR, 2022) |
| "Atherosclerosis is a hallmark of cardiovascular disease, and lifestyle strongly impacts its onset and progression." | ( Blanco, R; Daimiel, L; Dávalos, A; Díez-Ricote, L; Micó, V; Ordovás, JM; Ruiz-Valderrey, P; Tomé-Carneiro, J, 2022) |
| "Atherosclerosis is a main cause of multiple cardiovascular diseases, and cell damage of human umbilical vein endothelial cells (HUVECs) was reported to participate in the development of atherosclerosis." | ( Chen, D; Du, Y; Ye, S; Yu, J, 2023) |
| "Atherosclerosis is a chronic inflammatory vascular disease in which endothelial cells play an important role in maintaining vascular homeostasis." | ( Li, H; Li, Y; Su, M; Weng, J; Xu, S; Zhao, W, 2022) |
| "Atherosclerosis is an inflammatory disease depending on the buildup, called plaque, of lipoproteins, cholesterol, extracellular matrix elements, and various types of immune and non-immune cells on the artery walls." | ( Ghobrial, RM; Kloc, M; Kubiak, JZ, 2022) |
| "Atherosclerosis is an inflammatory disease depending on the buildup, called plaque, of lipoproteins, cholesterol, extracellular matrix elements, and various types of immune and non-immune cells on the artery walls." | ( Ghobrial, RM; Kloc, M; Kubiak, JZ, 2022) |
| "Atherosclerosis is an inflammatory disease depending on the buildup, called plaque, of lipoproteins, cholesterol, extracellular matrix elements, and various types of immune and non-immune cells on the artery walls." | ( Ghobrial, RM; Kloc, M; Kubiak, JZ, 2022) |
| "Atherosclerosis is an increasingly public health issue globally." | ( Mao, Q; Sun, Y; Xu, S; Zhao, J; Zhao, X; Zhou, D, 2023) |
| "Atherosclerosis is an increasingly public health issue globally." | ( Mao, Q; Sun, Y; Xu, S; Zhao, J; Zhao, X; Zhou, D, 2023) |
| "Atherosclerosis is a complex metabolic disease characterized by the dysfunction of lipid metabolism and chronic inflammation in the intimal space of the vessel." | ( Guo, Z; Liu, H; Wang, L; Xie, Y, 2022) |
| "Atherosclerosis is a chronic inflammation characterized by macrophage infiltration, lipid deposition, and arterial wall thickening." | ( Almassabi, R; Almowallad, S; Huwait, E; Kalamegam, G; Karim, S; Mirza, Z; Saddeek, S, 2022) |
| "Atherosclerosis is a chronic disease initiated by lipid-mediated vascular inflammation." | ( Duan, Y; Gong, K; Guo, Q; Jing, H; Li, Z; Sun, Y; Tian, Y; Wang, Q; Wu, Z; Zhang, J, 2023) |
| "Atherosclerosis is associated with inflammation in the arteries, a significant cause of heart attacks and strokes." | ( Gao, T; Jiang, L; Li, F; Li, S; Liu, M; Shi, B, 2023) |
| "Atherosclerosis is a chronic inflammatory disease, in which immune disorders constitute an essential part of vascular pathogenesis." | ( Cai, Z; Liu, L; Liu, M; Ma, D; Wang, F; Wang, J; Xu, Y; Zhai, C; Zhang, W; Zhao, L, 2023) |
| "Atherosclerosis is the main cause of cardiovascular disease, and fluid shear stress is a key factor regulating its occurrence and development." | ( Li, S; Liu, B; Meng, Q; Pu, L; Wang, Y, 2023) |
| "Atherosclerosis is driven by synergistic interactions between pathological biomechanical and lipid metabolic factors." | ( Afina, B; Bai, X; Chen, H; Fan, Y; Hong, Y; Jia, X; Kopylov, P; Li, X; Liu, W; Liu, X; Meng, Z; Shchekochikhin, D; Sun, H; Tang, X; Wang, L; Zhang, Y; Zhao, H; Zhong, X, 2023) |
| "Atherosclerosis is characterized by the accumulation of lipid-laden cells in the arterial walls, resulting from dysregulation of cholesterol homeostasis in the macrophage, triggered by oxidized low-density lipoprotein (oxLDL)." | ( Aguilar, EC; Alvarez-Leite, JI; Andrade, LO; Ávila, DL; Barros, ALB; Capettini, LDSA; Fernandes-Braga, W; Miranda, SEM; Navia-Pelaez, JM; Rezende, L, 2023) |
| "Atherosclerosis is a focal chronic inflammatory disease, the initial pathogenic event of which is endothelial dysfunction, and disturbed flow (DF) is the primary and vital factor underlying endothelial dysfunction." | ( Chen, S; Gao, X; Kong, X; Luo, S; Qian, X; Wang, F; Wang, Z; Zhang, J; Zhou, W, 2023) |
| "Atherosclerosis is the most prevalent cardiovascular disease and remains the major contributor to death and mortality globally." | ( Gao, X; Song, L; Xiang, D; Xie, D; Zhao, W, 2023) |
| "Atherosclerosis is one of the most important global health hazards and air pollution (AP, PM2." | ( Celermajer, DS; Chook, P; Guo, DS; Kwok, CYT; Lin, CQ; Poon, YKP; Woo, KS; Yin, YH, 2023) |
| "The culprits of atherosclerosis are endothelial damage, local disorders of lipid metabolism, and progressive inflammation." | ( Li, G; Ma, B; She, P; Wang, Y; Xu, H; Zhao, Z, 2023) |
| "Atherosclerosis is a major contributor to the onset and progression of cardiovascular disease (CVD)." | ( Mukherjee, A; Ray, A; Sacher, S, 2023) |
| "Atherosclerosis is a systemic pro-inflammatory and pro-oxidative disease, accounting for approximately a third of deaths globally." | ( Delaney, CL; Miller, MD; Nayda, NC; Thomas, JM, 2023) |
| "Atherosclerosis is a chronic inflammatory disease of arterial wall, which is closely related to inflammatory reaction." | ( Gu, ZW; Jiang, HQ; Li, J; Li, YL; Qi, DM; Wang, DY; Wang, LH; Yang, WQ, 2023) |
| "Atherosclerosis is a chronic inflammatory disease of the arterial wall involving inflammation, redox imbalance, and impaired cholesterol transport." | ( Ancuta, B; Cismaru, G; Decea, N; Filip, GA; Florea, CM; Moldovan, R; Rosu, R; Toma, V; Vlase, L, 2022) |
| "Atherosclerosis is complex chronic disease characterized by intimal cholesterol accumulation and vascular inflammation." | ( Abburi, K; Cochran, BJ; Ephraums, J; King, TW; Rye, KA; Tucker, B, 2023) |
| "Atherosclerosis is the most common cardiovascular disease and is the number one cause of death worldwide." | ( Bogatyreva, AI; Breshenkov, DG; Chakal, DA; Charchyan, ER; Markin, AM; Markina, YV; Tolstik, TV, 2023) |
| "Atherosclerosis is a common chronic inflammatory disease." | ( Fang, Z; Huang, Z; Li, W; Liang, G; Lin, L; Luo, W; Shen, S; Wu, G, 2023) |
| "Atherosclerosis is characterized by the accumulation of lipids and immune cells, including mast cells and B cells, in the arterial wall." | ( Bernabé Kleijn, MNA; Biskop, D; Bot, I; Delfos, L; Depuydt, MAC; Foks, AC; Hemme, E; Kuiper, J; Smit, V, 2023) |
| "Atherosclerosis is one of the most urgent global health subjects, causes millions of deaths worldwide, and is associated with enormous healthcare costs." | ( Breunig, M; Fleischmann, D; Goepferich, AM; Groner, J; Mietzner, R; Tognazzi, M; Walter, M; Ziegler, CE, 2023) |
| "Atherosclerosis is a common and serious vascular disease that underlies many cardiovascular and cerebrovascular illnesses, including heart attack and stroke." | ( Hadi, NR; Mohammad, B; Sahib, HH, 2023) |
| "Atherosclerosis is a complex pathological condition marked by the accumulation of lipids in the arterial wall, leading to the development of plaques that can eventually rupture and cause thrombotic events." | ( Munteanu, C, 2023) |
| "We argue that atherosclerosis is not observed in HH because iron homeostasis in the arterial wall, the actual location of atherosclerosis, is not significantly affected, and support a causal link between iron in the arterial wall and atherosclerosis." | ( Guo, Q; Qian, C; Qian, ZM, 2023) |
| "Atherosclerosis is widely deemed as a chronic inflammation disease, and as the basis of vascular obstructive disease." | ( Cui, S; Feng, G; Han, D; He, Q; Hu, Q; Tao, B; Wang, L; Wu, H; Wu, Q; Xia, H; Xu, L; Yi, X, 2023) |
| "Atherosclerosis is a complex, multi-stage disease characterized by pathological changes across the vascular wall." | ( Huang, SL; Kim, H; McPherson, DD; Moody, MR; Yin, X, 2023) |
| "Atherosclerosis is a huge threaten to the human health, C1q/TNF-related protein 9 (CTRP9) has been previously reported possessing vascular protective functions." | ( He, Y; Wei, X; Yang, Y; Zeng, M, 2023) |
| "Atherosclerosis is driven by a diverse range of cellular and molecular processes." | ( Kapelouzou, A; Mylonas, KS; Peroulis, M; Schizas, D, 2023) |
| "Atherosclerosis is a chronic, inflammatory disease characterized by a lipid-driven infiltration of inflammatory cells in large and medium arteries and is considered to be a major underlying cause of cardiovascular diseases." | ( Chen, YT; Lin, L; Tian, S; Wu, GF; Xu, XH, 2023) |
| "Atherosclerosis is a chronic inflammatory disease." | ( Gong, C; Li, H; Liu, D; Zhao, G; Zhao, Q; Zhou, B, 2023) |
| "Atherosclerosis is the major cause of cardiovascular-disease-related death worldwide, resulting from the subendothelial accumulation of lipoprotein-derived cholesterol, ultimately leading to chronic inflammation and the formation of clinically significant atherosclerotic plaques." | ( Dabravolski, SA; Khotina, VA; Melnichenko, AA; Orekhov, AN; Sukhorukov, VN, 2023) |
| "Atherosclerosis is a major cause of cerebral and cardiovascular diseases." | ( Hanafusa, K; Hirabayashi, Y; Iwabuchi, K; Kano, K; Kato, M; Matsuo, I; Minamino, T; Miyazaki, T; Nakayama, H; Oshima, E; Shimai, R; Tokano, T, 2023) |
| "Coronary atherosclerosis is closely related to inflammation and oxidative stress." | ( Chen, J; Han, X; Huang, N; Liu, L; Lu, B; Luo, X; Maitz, MF; Yang, P; Zhao, A; Zou, D, 2023) |
| "Atherosclerosis is more likely to occur in people with several risk factors, such as diabetes, hypertension, hyperlipidaemia, and smoking." | ( Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF, 2023) |
| "Atherosclerosis is a lipid-driven chronic inflammatory disease that poses a serious threat to health." | ( Cheng, L; Ke, BY; Qin, YS; Wang, SZ, 2023) |
| "Atherosclerosis is associated with various cardiovascular diseases (CVDs)." | ( Ahn, HS; Cho, EY; Yum, KS, 2023) |
| "Atherosclerosis is initiated by the activation of endothelial cells that allows monocyte adhesion and transmigration through the vascular wall." | ( Carmona, A; Guerrero, F; Jimenez, MJ; Martin-Malo, A; Muñoz-Castañeda, JR; Rodriguez, M; Soriano, S, 2023) |
| "Atherosclerosis is characterized by the formation of fibrofatty plaques in the intima of arteries, resulting in thickening of the vessel wall and narrowing of the lumen." | ( Chen, QL; Guo, ZG; Jiang, N; Li, JH; Wang, LQ; Yang, Y; Yao, BC, 2023) |
| "Atherosclerosis is considered the most common cause of morbidity and mortality worldwide." | ( Li, Z; Suguro, R; Suguro, S; Zhao, Y, 2023) |
| "Atherosclerosis is a progressive, degenerative vascular disease and a leading cause of morbidity and mortality." | ( Munshaw, S; Pike, BT; Redpath, AN; Smart, N, 2023) |
| "Atherosclerosis is a persistent inflammatory state that contributes significantly to cardiovascular disease, a primary cause of mortality worldwide." | ( Aoki, H; Aoyama, M; Hayashi, H; Inoue, Y; Kakita, H; Owaki, R; Takeshita, S; Toriuchi, K; Yamada, Y, 2023) |
| "Atherosclerosis is a chronic disease that thickens the blood vessel walls and narrows the lumen." | ( Chen, QL; Guo, SZ; Guo, ZG; Li, JH; Ma, YH; Wang, LQ; Yang, Y; Yao, BC, 2023) |
| "Atherosclerosis is the primary cause of cardiovascular disease." | ( Amaya-Garrido, A; Feuillet, G; Gayral, S; Grzesiak, L; Klein, J; Laffargue, M; Malet, N; Ramel, D; Sarthou, MK; Schanstra, JP; Swiader, A; Wahart, A, 2023) |
| "Atherosclerosis is a form of cardiovascular disease that affects the endothelium of the blood vessel." | ( Ajani, TA; Chauke, CG; Egieyeh, S; Magwebu, ZE; Obikeze, K, 2023) |
| "Atherosclerosis is a major cardiovascular complication of diseases associated with elevated oxidative stress such as type 2 diabetes and metabolic syndrome." | ( Delton, I; Luquain-Costaz, C, 2024) |